https://curecurrent.com/trials/genetic-determinants-of-the-metabolism-of-non-nucleoside-reverse-transcriptase-inhibitors-133009https://curecurrent.com/trials/exploration-of-hiv-reservoirs-133010https://curecurrent.com/trials/periodical-presumptive-treatment-for-the-control-of-gonococcal-infections-among-sex-workers-133011https://curecurrent.com/trials/attitudes-and-beliefs-and-the-steps-of-hiv-care-133012https://curecurrent.com/trials/reducing-hiv-safer-sex-skill-building-in-pregnant-drug-abusing-women-133013https://curecurrent.com/trials/study-to-explore-safety-and-tolerability-of-fosamprenavir-with-or-without-ritonavir-in-combination-with-trizivir-or-comb-133014https://curecurrent.com/trials/sgn-00101-in-preventing-anal-cancer-in-patients-with-hiv-who-have-anal-neoplasia-133015https://curecurrent.com/trials/safety-and-immunogenicity-of-a-plasmid-hiv-vaccine-in-hiv-uninfected-adults-133016https://curecurrent.com/trials/safety-and-immunogenicity-of-tbc-m4-a-mva-hiv-vaccine-alone-or-in-a-prime-boost-regimen-with-advax-dna-hiv-vaccine-133017https://curecurrent.com/trials/safety-and-immunogenicity-of-a-modified-vaccinia-ankara-mva-hiv-vaccine-in-hiv-uninfected-adults-133018https://curecurrent.com/trials/bms-275291-in-treating-patients-with-hiv-related-kaposi-s-sarcoma-133019https://curecurrent.com/trials/efficacy-of-raltegravir-in-a-large-urban-hiv-clinical-population-in-milan-133020https://curecurrent.com/trials/safety-and-immunogenicity-study-of-2-investigational-preventive-hiv-vaccines-133021https://curecurrent.com/trials/interleukin-12-following-chemotherapy-in-treating-patients-with-refractory-hiv-associated-non-hodgkin-s-lymphoma-133022https://curecurrent.com/trials/combination-chemotherapy-with-or-without-monoclonal-antibody-therapy-in-treating-patients-with-previously-untreated-hiv-133023https://curecurrent.com/trials/antiretroviral-sparing-concept-with-hiv-specific-t-cell-precursors-with-high-proliferative-capacity-phpc-133024https://curecurrent.com/trials/role-of-hiv-on-glutathione-synthesis-and-oxidative-stress-133025https://curecurrent.com/trials/influenza-vaccination-of-hiv-infected-pregnant-women-safety-and-immunogenicity-133026https://curecurrent.com/trials/altretamine-and-etoposide-in-treating-patients-with-hiv-related-cancer-133027https://curecurrent.com/trials/hiv-screening-in-the-emergency-department-setting-133028https://curecurrent.com/trials/effect-of-an-integrase-inhibitor-on-the-latency-and-reservoir-of-hiv-1-133029https://curecurrent.com/trials/pharmacokinetic-study-of-raltegravir-in-human-immunodeficiency-virus-hepatitis-c-virus-hiv-vhc-coinfected-patients-with-133030https://curecurrent.com/trials/preliminary-evaluation-of-a-point-of-care-liver-function-test-133031https://curecurrent.com/trials/drug-interaction-study-133032https://curecurrent.com/trials/phase-ii-study-of-ags-004-as-an-immunotherapeutic-in-antiretroviral-therapy-art-treated-subjects-infected-with-hiv-133033https://curecurrent.com/trials/folinic-acid-and-vascular-reactivity-in-hiv-133034https://curecurrent.com/trials/study-to-investigate-the-hemodynamic-effects-of-single-dose-vardenafil-in-subjects-receiving-maraviroc-133035https://curecurrent.com/trials/bryostatin-1-plus-vincristine-in-treating-patients-with-recurrent-or-refractory-hiv-related-lymphoma-133036https://curecurrent.com/trials/a-comparison-of-body-fat-distribution-in-hiv-1-infected-patients-receiving-since-the-beginning-and-for-at-least-two-year-133037https://curecurrent.com/trials/switching-the-non-nucleoside-reverse-transcriptase-inhibitor-nnrti-or-protease-inhibitor-pi-to-maraviroc-in-hiv-subjects-133038https://curecurrent.com/trials/typing-of-human-papilloma-virus-hpv-from-female-genital-warts-133039https://curecurrent.com/trials/prevention-of-pregnancy-associated-malaria-in-hiv-infected-women-cotrimoxazole-prophylaxis-versus-mefloquine-133040https://curecurrent.com/trials/study-of-hepatitis-c-virus-hcv-viral-kinetics-in-hiv-hcv-and-hcv-patients-133041https://curecurrent.com/trials/clinical-study-of-tuti-16-in-hiv-1-infected-and-uninfected-subjects-133042https://curecurrent.com/trials/kaletra-therapy-with-double-protease-inhibitors-133043https://curecurrent.com/trials/interactions-between-artemether-lumefantrine-and-antiretrovirals-in-hiv-patients-with-uncomplicated-malaria-in-tanzania-133044https://curecurrent.com/trials/hiv-and-hepatitis-care-coordination-in-methadone-treatment-133045https://curecurrent.com/trials/safety-and-immunogenicity-study-of-tgaac09-a-gag-pr-rt-aav-hiv-vaccine-133046https://curecurrent.com/trials/male-involvement-in-antenatal-care-and-the-prevention-programme-of-mother-to-child-transmission-of-hiv-in-uganda-133047https://curecurrent.com/trials/a-clinical-trial-comparing-the-tolerability-of-etravirine-to-efavirenz-in-combination-with-2-nucleoside-nucleotide-rever-133048https://curecurrent.com/trials/boosted-atazanavir-and-truvada-given-once-daily-baton-study-133049https://curecurrent.com/trials/lower-extremity-splinting-to-manage-pain-and-sleep-disturbances-associated-with-hiv-aids-related-peripheral-neuropathy-133050https://curecurrent.com/trials/safety-of-lopinavir-ritonavir-kaletra-in-hiv-hcv-co-infected-subjects-vs-baseline-liver-biopsy-metavir-score-133051https://curecurrent.com/trials/randomized-control-trial-of-shang-ring-versus-forceps-guided-adult-male-circumcision-in-southwestern-uganda-133052https://curecurrent.com/trials/study-of-human-papillomavirus-related-genital-pathology-among-hiv-positive-women-133053https://curecurrent.com/trials/effectiveness-of-hepatitis-a-virus-vaccination-among-homosexual-males-at-risk-for-hepatitis-a-infection-133054https://curecurrent.com/trials/accelerated-aging-hiv-infection-antiretroviral-therapies-133055https://curecurrent.com/trials/patients-infected-with-hiv-since-more-than-10-years-with-a-plasma-viral-rna-400-copies-ml-in-the-absence-of-any-treatmen-133056https://curecurrent.com/trials/utility-of-sputum-induction-and-novel-technologies-to-improve-tb-diagnosis-in-a-high-hiv-prevalence-primary-care-setting-133057https://curecurrent.com/trials/use-of-incentives-to-engage-drug-users-in-hiv-therapy-133058https://curecurrent.com/trials/raltegravir-therapy-for-women-with-hiv-and-fat-accumulation-133059https://curecurrent.com/trials/a-study-of-trimetrexate-with-leucovorin-rescue-for-aids-patients-who-are-refractory-to-standard-therapies-for-pneumocyst-133060https://curecurrent.com/trials/effects-of-mixed-exercise-regime-and-l-carnitine-supplementation-in-hiv-patients-on-haart-133061https://curecurrent.com/trials/treatment-simplification-by-darunavir-ritonavir-800-100-mg-once-a-day-versus-a-triple-combination-therapy-with-darunavir-133062https://curecurrent.com/trials/the-tolerance-of-hiv-infected-patients-with-herpes-group-virus-infections-to-oral-doses-of-fiau-133063https://curecurrent.com/trials/safety-study-of-ibalizumab-subcutaneous-injection-in-healthy-volunteers-133064https://curecurrent.com/trials/the-safety-and-effectiveness-of-fiac-in-the-treatment-of-cytomegalovirus-cmv-in-patients-with-aids-133065https://curecurrent.com/trials/study-of-niacin-on-endothelial-function-in-hiv-infected-subjects-with-low-high-density-lipoprotein-cholesterol-levels-133066https://curecurrent.com/trials/safety-and-immunogenicity-study-of-tgaac09-an-hiv-vaccine-in-an-adeno-associated-virus-aav-capsid-133067https://curecurrent.com/trials/safety-and-immunogenicity-study-of-ad26-enva-and-ad35-env-hiv-vaccines-in-healthy-hiv-uninfected-adults-133068https://curecurrent.com/trials/treatment-of-anemia-and-neutropenia-in-hiv-hcv-coinfected-patients-treated-with-pegylated-interferon-and-ribavirin-133069https://curecurrent.com/trials/development-of-a-methamphetamine-early-intervention-133070https://curecurrent.com/trials/study-on-immunopathogenesis-in-hiv-and-hepatitis-c-coinfection-133071https://curecurrent.com/trials/mobile-phone-text-messaging-referral-133072https://curecurrent.com/trials/tmc125hiv1083-swallowability-of-uncoated-200-mg-etravirine-tablets-in-hiv-1-infected-patients-133073https://curecurrent.com/trials/reactogenicity-and-immunogenicity-of-cervico-vaginal-cn54gp140-hsp70-conjugate-vaccine-133074https://curecurrent.com/trials/partner-specific-hiv-risk-reduction-intervention-for-drug-using-adolescents-133075https://curecurrent.com/trials/an-open-label-trial-of-the-effect-of-valacyclovir-on-plasma-hiv-1-levels-among-hiv-1-seropositive-and-hsv-1-2-seronegati-133076https://curecurrent.com/trials/comparative-tolerability-of-protease-inhibitors-133077https://curecurrent.com/trials/trial-of-three-neonatal-antiretroviral-regimens-for-prevention-of-intrapartum-hiv-transmission-133078https://curecurrent.com/trials/maraviroc-ccr5-antagonism-to-decrease-the-incidence-of-the-immune-reconstitution-inflammatory-syndrome-in-hiv-infected-p-133079https://curecurrent.com/trials/an-evaluation-of-a-rapid-test-for-hiv-133080https://curecurrent.com/trials/pharmacokinetic-interactions-between-buprenorphine-and-kaletra-lopinavir-ritonavir-133081https://curecurrent.com/trials/buprenorphine-raltegravir-pharmacokinetic-interaction-study-133082https://curecurrent.com/trials/tmc278-tidp15-c158-a-study-to-examine-the-safety-tolerability-and-pharmacokinetics-of-a-single-dose-or-three-successive-133083https://curecurrent.com/trials/a-study-of-anti-hiv-monoclonal-antibody-kd-247-133084https://curecurrent.com/trials/study-of-pennvax-b-gag-pol-env-electroporation-in-hiv-1-infected-adult-participants-133085https://curecurrent.com/trials/a-multicentre-trial-of-second-line-antiretroviral-treatment-strategies-in-african-adults-using-atazanavir-or-lopinavir-r-133086https://curecurrent.com/trials/a-study-to-examine-the-human-papillomavirus-types-exposure-in-women-from-southern-africa-and-brasil-133087https://curecurrent.com/trials/non-interventional-study-of-celsentri-in-treatment-experienced-patients-with-ccr5-tropic-hiv-infection-133088https://curecurrent.com/trials/immune-therapies-and-anti-hiv-therapy-withdrawal-in-controlling-viral-load-133089https://curecurrent.com/trials/depo-medroxyprogesterone-acetate-dmpa-depo-provera-use-with-certain-anti-hiv-drugs-in-hiv-infected-women-133090https://curecurrent.com/trials/hpmpc-cidofovir-peripheral-cmv-retinitis-trial-protocol-133091https://curecurrent.com/trials/a-phase-i-study-to-evaluate-the-safety-and-toxicity-of-the-combination-of-zidovudine-and-2-3-dideoxyinosine-didanosine-i-133092https://curecurrent.com/trials/phase-ii-trial-of-sequential-chemotherapy-and-radiotherapy-for-aids-related-primary-central-nervous-system-lymphoma-133093https://curecurrent.com/trials/the-safety-and-effectiveness-of-rifabutin-combined-with-clarithromycin-or-azithromycin-in-hiv-infected-patients-133094https://curecurrent.com/trials/a-study-to-prepare-for-future-hiv-vaccine-studies-133095https://curecurrent.com/trials/hiv-and-cardiovascular-risk-133096https://curecurrent.com/trials/prevalence-of-hepatitis-c-virus-infection-in-hiv-infected-children-133097https://curecurrent.com/trials/evaluation-of-treatment-for-mycobacterium-avium-complex-mac-infection-in-hiv-infected-patients-133098https://curecurrent.com/trials/a-phase-i-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-200-mcg-of-gp120-cho-biocine-in-mf59-emulsion-vers-133099https://curecurrent.com/trials/safety-of-and-immune-response-to-an-hiv-vaccine-sf-2-gp120-with-or-without-mtp-pe-mf59-adjuvant-133100https://curecurrent.com/trials/voluntary-hiv-counseling-testing-and-medication-for-pregnant-women-to-prevent-mother-to-child-hiv-transmission-133101https://curecurrent.com/trials/effect-of-tenofovir-disoproxil-fumarate-on-lipid-levels-in-hiv-infected-adults-on-stable-anti-hiv-drug-therapy-133102https://curecurrent.com/trials/safety-and-effectiveness-of-administering-an-hiv-vaccine-in-the-groin-versus-the-arm-133103https://curecurrent.com/trials/a-randomized-prospective-study-of-pyrimethamine-therapy-for-prevention-of-toxoplasmic-encephalitis-in-hiv-infected-indiv-133104https://curecurrent.com/trials/safety-effectiveness-and-tolerability-of-ezetimibe-combined-with-statins-for-the-treatment-of-high-cholesterol-in-hiv-in-133105https://curecurrent.com/trials/anti-hiv-medications-and-structured-treatment-interruptions-for-people-recently-infected-with-hiv-133106https://curecurrent.com/trials/outcomes-of-anti-hiv-therapy-during-early-hiv-infection-133107https://curecurrent.com/trials/directly-observed-therapy-in-hiv-infected-adolescent-focus-groups-133108https://curecurrent.com/trials/long-term-follow-up-of-hiv-infected-patients-identified-during-early-infection-133109https://curecurrent.com/trials/is-tuberculin-skin-testing-effective-in-screening-for-latent-tuberculosis-in-patients-with-hiv-133110https://curecurrent.com/trials/antiretroviral-resistance-detection-by-ultrasensitive-pyrosequencing-of-the-hiv-1-genome-and-virological-response-to-ant-133111https://curecurrent.com/trials/a-phase-ii-iii-trial-of-human-anti-cmv-monoclonal-antibody-msl-109-macrt-133112https://curecurrent.com/trials/computer-assisted-tailored-cue-card-health-catch-study-133113https://curecurrent.com/trials/drug-interactions-between-voriconazole-and-atazanavir-coadministered-as-atazanavir-ritonavir-in-healthy-participants-133114https://curecurrent.com/trials/long-term-assessment-for-metabolic-cardiovascular-and-neurologic-problems-in-hiv-infected-patients-with-increased-cd4-ce-133115https://curecurrent.com/trials/the-prevalence-of-neurocognitive-disorder-in-a-primary-care-based-hiv-cohort-compared-to-a-hiv-negative-control-cohort-133116https://curecurrent.com/trials/study-of-the-antiviral-and-immunological-effects-of-intensification-of-suppressive-antiretroviral-therapy-with-maraviroc-133117https://curecurrent.com/trials/tuberculosis-prevention-for-hiv-infected-adults-133118https://curecurrent.com/trials/the-safety-and-efficacy-of-clindamycin-and-primaquine-in-the-treatment-of-mild-moderate-pneumocystis-carinii-pneumonia-i-133119https://curecurrent.com/trials/a-study-of-atvogen-in-healthy-volunteers-and-hiv-infected-patients-who-have-no-symptoms-of-infection-133120https://curecurrent.com/trials/safety-study-of-il-7-in-hiv-infected-patients-inspire-133121https://curecurrent.com/trials/modeling-study-to-predict-progression-of-anal-cancer-pre-cursor-lesions-in-hiv-133122https://curecurrent.com/trials/multicentre-study-to-assess-changes-in-bone-mineral-density-of-the-switch-from-tenofovir-to-abacavir-in-hiv-1-infected-s-133123https://curecurrent.com/trials/rifampin-and-efavirenz-interactions-in-older-children-133124https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-and-safety-of-gsk1265744-and-rilpivirine-and-dolutegravir-and-rilpivirine-in-he-133125https://curecurrent.com/trials/pharmacokinetic-study-of-raltegravir-in-healthy-premenopausal-women-133126https://curecurrent.com/trials/evaluation-of-the-bioequivalence-of-a-combined-formulated-tablet-133127https://curecurrent.com/trials/analysis-on-the-risk-of-cardiovascular-events-in-hiv-infected-subjects-treated-with-lpv-r-based-haart-regimen-vs-an-efv-133128https://curecurrent.com/trials/rifampin-and-nevirapine-interactions-in-young-children-133129https://curecurrent.com/trials/pharmacokinetics-of-anti-tb-drugs-in-hiv-tb-co-infected-children-in-ghana-133130https://curecurrent.com/trials/electronic-intervention-for-hiv-medication-adherence-133131https://curecurrent.com/trials/single-dose-truvada-in-hiv-negative-men-and-women-133132https://curecurrent.com/trials/comparing-raltegravir-genital-tract-distribution-in-hiv-infected-men-and-women-133133https://curecurrent.com/trials/protease-inhibitor-monotherapy-versus-ongoing-triple-therapy-in-the-long-term-management-of-hiv-infection-pivot-133134https://curecurrent.com/trials/artery-elasticity-after-switch-from-epzicom-to-truvada-133135https://curecurrent.com/trials/a-pilot-study-on-raltegravir-tenofovir-and-emtricitabine-for-peri-exposure-prophylaxis-for-hiv-infection-133136https://curecurrent.com/trials/an-evaluation-of-immunogenicity-and-safety-of-two-doses-of-mva-nef-vs-mva-bn-in-hiv-1-infected-patients-133137https://curecurrent.com/trials/safety-tolerability-and-immune-response-of-imvamune-mva-bn-smallpox-vaccine-in-hiv-infected-patients-133138https://curecurrent.com/trials/std-risk-reduction-for-heterosexual-methamphetamine-users-133139https://curecurrent.com/trials/acyclovir-to-treat-patients-co-infected-with-hiv-and-herpes-viruses-in-uganda-133140https://curecurrent.com/trials/behavior-change-and-maintenance-intervention-for-hiv-msm-methamphetamine-users-133141https://curecurrent.com/trials/community-intervention-trial-for-youth-city-study-133142https://curecurrent.com/trials/behavioral-intervention-for-hiv-and-hcv-uninfected-injection-drug-users-133143https://curecurrent.com/trials/behavioral-intervention-trial-for-hiv-infected-injection-drug-users-133144https://curecurrent.com/trials/the-treatment-advocacy-program-133145https://curecurrent.com/trials/pediatric-impact-promoting-adherence-to-medications-among-hiv-infected-children-133146https://curecurrent.com/trials/video-based-intervention-study-to-prevent-hiv-sexually-transmitted-diseases-stds-among-std-clinic-patients-133147https://curecurrent.com/trials/parents-matter-interventions-to-promote-effective-parent-child-communication-133148https://curecurrent.com/trials/feasibility-of-a-lateral-flow-urine-lam-test-for-diagnosis-of-tuberculosis-in-south-africa-133149https://curecurrent.com/trials/hiv-vaccine-study-in-hiv-positive-patients-133150https://curecurrent.com/trials/sex-aging-and-antiretroviral-pharmacokinetics-133151https://curecurrent.com/trials/estimate-the-effect-of-telaprevir-and-boceprevir-on-maraviroc-pharmacokinetics-in-healthy-subjects-133152https://curecurrent.com/trials/directly-observed-therapy-for-hiv-infected-adolescents-133153https://curecurrent.com/trials/study-of-vitamin-d-supplementation-to-male-hiv-sero-positive-patients-133154https://curecurrent.com/trials/the-adult-antiretroviral-treatment-and-resistance-study-tshepo-133155https://curecurrent.com/trials/trial-of-zinc-and-hiv-progression-in-children-133156https://curecurrent.com/trials/lifestyle-modification-and-metformin-use-in-the-treatment-of-hiv-133157https://curecurrent.com/trials/study-to-evaluate-the-treatment-for-chronic-hepatitis-c-with-normal-transaminases-in-hiv-positive-patients-133158https://curecurrent.com/trials/efficacy-of-hiv-post-test-support-for-anc-in-south-africa-133159https://curecurrent.com/trials/episodic-acyclovir-therapy-for-genital-ulcers-133160https://curecurrent.com/trials/lay-health-advisors-for-sexually-transmitted-disease-prevention-133161https://curecurrent.com/trials/multi-level-interventions-for-std-prevention-among-adolescents-133162https://curecurrent.com/trials/adopting-and-demonstrating-the-adaptation-of-prevention-techniques-adapt-harlem-united-community-aids-center-133163https://curecurrent.com/trials/comparison-of-facility-and-home-based-art-delivery-systems-in-uganda-133164https://curecurrent.com/trials/hip-hiv-intervention-for-providers-133165https://curecurrent.com/trials/home-based-aids-care-project-133166https://curecurrent.com/trials/hiv-indicator-diseases-across-europe-study-133167https://curecurrent.com/trials/trial-to-evaluate-pro-2000-5-gels-for-the-prevention-of-vaginally-acquired-hiv-infection-133168https://curecurrent.com/trials/maintaining-hiv-prevention-gains-in-female-adolescents-133169https://curecurrent.com/trials/a-study-to-evaluate-antiviral-activity-of-darunavir-ritonavir-in-hiv-1-infected-adolescents-133170https://curecurrent.com/trials/effects-of-famotidine-on-the-pharmacokinetics-of-atazanavir-when-coadministered-to-participants-with-hiv-infection-133171https://curecurrent.com/trials/a-knowledge-translation-intervention-for-tb-hiv-treatment-adherence-in-zomba-district-malawi-133172https://curecurrent.com/trials/tmc125ifd1001-drug-drug-interaction-of-etravirine-with-telaprevir-and-tmc278-with-telaprevir-133173https://curecurrent.com/trials/sleep-quality-and-presence-of-sleep-disordered-breathing-133174https://curecurrent.com/trials/highly-active-antiretroviral-therapy-haart-adherence-interventions-133175https://curecurrent.com/trials/antiretroviral-therapy-intensification-with-raltegravir-or-addition-of-hyper-immune-bovine-colostrum-in-hiv-1-infected-p-133176https://curecurrent.com/trials/determination-of-optimum-age-for-dxa-screening-for-osteoporosis-in-hiv-the-probono-1-study-133177https://curecurrent.com/trials/adapt-pol-new-orleans-adaptation-of-prevention-techniques-with-popular-opinion-leader-133178https://curecurrent.com/trials/botswana-study-of-uc-781-vaginal-microbicide-133179https://curecurrent.com/trials/tmc207-tidp13-c110-interaction-study-with-lopinavir-ritonavir-in-healthy-volunteer-133180https://curecurrent.com/trials/community-reinforcement-and-family-training-for-drug-abuse-treatment-retention-hiv-risk-reduction-133181https://curecurrent.com/trials/earnest-rifabutin-pharmacokinetics-pk-substudy-133182https://curecurrent.com/trials/hiv-testing-and-brief-alcohol-intervention-for-young-drinkers-in-the-emergency-department-133183https://curecurrent.com/trials/preference-of-genetic-polymorphism-and-pharmacokinetics-133184https://curecurrent.com/trials/safety-and-efficacy-of-oral-immunomodulator-in-tuberculosis-tb-and-tb-hiv-patients-133185https://curecurrent.com/trials/study-of-bone-disease-in-older-hiv-infected-adults-133186https://curecurrent.com/trials/switch-to-atazanavir-and-brachial-artery-reactivity-sabar-study-133187https://curecurrent.com/trials/vitamin-d-supplementation-in-hiv-infected-youth-133188https://curecurrent.com/trials/renal-function-assessment-in-hiv-patient-133189https://curecurrent.com/trials/further-investigation-of-an-intramuscular-influenza-vaccine-multimeric-001-133190https://curecurrent.com/trials/study-of-pharmacokinetics-in-hiv-infected-women-133191https://curecurrent.com/trials/monotherapy-versus-placebo-over-10-days-in-integrase-naive-hiv-1-infected-adults-133192https://curecurrent.com/trials/single-ascending-dose-sad-multiple-ascending-dose-mad-safety-pharmacokinetic-pk-study-of-km-023-133193https://curecurrent.com/trials/a-study-of-hiv-levels-during-pregnancy-and-after-childbirth-133194https://curecurrent.com/trials/pilot-study-on-the-effect-of-adding-raltegravir-a-second-drug-on-hiv-levels-in-the-gut-133195https://curecurrent.com/trials/two-approaches-to-routine-hiv-testing-in-a-hospital-emergency-department-133196https://curecurrent.com/trials/isoniazid-plus-antiretroviral-therapy-to-prevent-tuberculosis-in-hiv-infected-persons-133197https://curecurrent.com/trials/impact-of-different-contraceptives-on-the-immune-system-of-hiv-infected-women-in-zambia-133198https://curecurrent.com/trials/managed-problem-solving-to-increase-treatment-adherence-in-individuals-with-hiv-133199https://curecurrent.com/trials/effect-of-medication-diaries-on-adherence-to-highly-active-antiretroviral-drugs-among-hiv-1-infected-kenyan-children-133200https://curecurrent.com/trials/evaluation-of-use-of-clinical-decision-support-system-in-hiv-care-in-resource-constrained-settings-133201https://curecurrent.com/trials/lopinavir-ritonavir-kaletra-pk-in-children-133202https://curecurrent.com/trials/addressing-proven-factors-in-hiv-prevention-for-latino-youth-133203https://curecurrent.com/trials/safety-of-an-hiv-vaccine-avx101-in-hiv-uninfected-volunteers-in-the-united-states-and-south-africa-133204https://curecurrent.com/trials/safety-of-and-immune-response-to-an-hiv-1-subtype-c-vaccine-avx101-in-hiv-uninfected-adults-133205https://curecurrent.com/trials/smoking-treatment-in-hiv-clinical-care-settings-133206https://curecurrent.com/trials/acupuncture-moxibustion-acu-moxa-for-distal-symmetric-peripheral-neuropathy-dsp-in-hiv-133207https://curecurrent.com/trials/acupuncture-for-nausea-in-hiv-133208https://curecurrent.com/trials/intranasal-modified-vacc-4x-gag-peptides-with-endocine-as-adjuvant-133209https://curecurrent.com/trials/a-pilot-study-of-a-novel-treatment-regimen-maraviroc-ritonavir-boosted-atazanavir-in-treatment-naive-hiv-infected-patien-133210https://curecurrent.com/trials/a-behavioral-intervention-to-reduce-sexual-risk-among-african-american-men-who-have-sex-with-men-133211https://curecurrent.com/trials/a-network-intervention-for-reducing-sexual-risk-for-hiv-with-african-american-men-who-have-sex-with-men-aa-msm-133212https://curecurrent.com/trials/two-approaches-to-routine-hiv-testing-in-a-hospital-emergency-department-133213https://curecurrent.com/trials/thai-prophylactic-hiv-vaccine-phase-i-study-133214https://curecurrent.com/trials/study-of-lopinavir-ritonavir-and-lamivudine-versus-standard-therapy-in-na-ve-hiv-1-infected-subjects-133215https://curecurrent.com/trials/evolution-of-cellular-and-viral-resistance-in-hiv-infected-patients-with-lymphoma-133216https://curecurrent.com/trials/a-phase-1-open-label-placebo-controlled-study-to-evaluate-the-effect-of-gsk1349572-on-iohexol-and-para-aminohippurate-cl-133217https://curecurrent.com/trials/a-safety-and-efficacy-trial-of-dapivirine-vaginal-ring-in-africa-133218https://curecurrent.com/trials/a-safety-and-efficacy-trial-of-dapivirine-vaginal-ring-in-africa-133219https://curecurrent.com/trials/hiv-1-infection-study-of-once-a-day-versus-twice-a-day-protease-inhibitor-in-antiretroviral-treatment-naive-adults-133220https://curecurrent.com/trials/predictors-of-antiretroviral-pharmacokinetics-in-hiv-infected-women-with-virologic-suppression-133221https://curecurrent.com/trials/a-study-to-evaluate-various-combinations-of-anti-hiv-medications-to-treat-early-hiv-infection-133222https://curecurrent.com/trials/family-based-hiv-prevention-for-latinos-133223https://curecurrent.com/trials/improving-latent-tuberculosis-tb-diagnosis-in-thai-children-133224https://curecurrent.com/trials/fuzeon-viral-decay-pilot-study-133225https://curecurrent.com/trials/leukapheresis-to-obtain-lymphocytes-for-studies-on-antiretroviral-naive-hiv-infected-patients-133226https://curecurrent.com/trials/integrase-inhibitor-mk-0518-viral-decay-133227https://curecurrent.com/trials/safety-efficacy-and-psychological-effects-of-treating-antiretroviral-drug-induced-facial-lipoatrophy-with-bio-alcamid-133228https://curecurrent.com/trials/tbtc-study-23c-pharmacokinetics-of-intermittent-rifabutin-and-isoniazid-with-daily-efavirenz-133229https://curecurrent.com/trials/study-to-assess-safety-and-quality-of-life-of-patients-using-biojector-versus-needles-for-fuzeon-administration-133230https://curecurrent.com/trials/a-study-to-evaluate-formulations-and-food-effect-on-gsk364735-in-healthy-subjects-133231https://curecurrent.com/trials/relapse-prevention-to-reduce-hiv-among-women-prisoners-133232https://curecurrent.com/trials/behavioral-activation-and-hiv-risk-reduction-for-men-who-have-sex-with-men-with-crystal-meth-abuse-133233https://curecurrent.com/trials/maternal-tdf-and-ftc-to-reduce-nnrti-resistance-mutations-after-intrapartum-nvp-133234https://curecurrent.com/trials/kaletra-monotherapy-in-hiv-hcv-co-infected-subjects-133235https://curecurrent.com/trials/safety-and-efficacy-study-of-switching-from-epzicom-to-truvada-133236https://curecurrent.com/trials/pilot-study-of-metabolic-syndromes-and-hiv-infections-in-indian-tibetans-133237https://curecurrent.com/trials/addition-of-efavirenz-or-nelfinavir-to-a-lamivudine-zidovudine-indinavir-hiv-treatment-regimen-133238https://curecurrent.com/trials/a-phase-ii-study-of-intermittent-recombinant-human-interleukin-2-rhil-2-by-intravenous-or-subcutaneous-administration-in-133239https://curecurrent.com/trials/a-study-to-evaluate-the-bioequivalence-of-a-combined-formulated-tablet-compared-with-maraviroc-and-combivir-133240https://curecurrent.com/trials/treatment-with-interleukin-2-il-2-plus-combination-anti-hiv-drug-therapy-haart-for-patients-formerly-in-actg-328-133241https://curecurrent.com/trials/drug-interaction-study-between-dolutegravir-and-an-oral-contraceptive-containing-norgestimate-and-ethinylestradiol-133242https://curecurrent.com/trials/comparison-of-three-different-initial-treatments-without-protease-inhibitors-for-hiv-infection-133243https://curecurrent.com/trials/a-study-to-compare-the-ability-of-different-anti-hiv-drugs-to-decrease-viral-load-after-nelfinavir-an-anti-hiv-drug-trea-133244https://curecurrent.com/trials/study-of-anti-hiv-therapy-intensification-133245https://curecurrent.com/trials/differences-between-stavudine-and-tenofovir-each-combined-with-lamivudine-and-efavirenz-in-sa-hiv-infected-patients-133246https://curecurrent.com/trials/a-pilot-study-of-oral-clindamycin-and-pyrimethamine-for-the-treatment-of-toxoplasmic-encephalitis-in-patients-with-aids-133247https://curecurrent.com/trials/pilot-study-of-raltegravir-lipodystrophy-iisp-133248https://curecurrent.com/trials/a-phase-i-study-of-the-safety-and-immunogenicity-of-rgp120-hiv-1iiib-vaccine-in-healthy-adult-subjects-note-study-extend-133249https://curecurrent.com/trials/discontinuation-of-primary-and-secondary-prophylaxis-for-opportunistic-infections-in-hiv-infected-patients-133250https://curecurrent.com/trials/a-study-comparing-long-acting-methylphenidate-concertatm-vs-placebo-in-the-treatment-of-memory-loss-due-to-hiv-133251https://curecurrent.com/trials/trial-of-maraviroc-uk-427-857-in-combination-with-optimized-background-therapy-versus-optimized-background-therapy-alone-133252https://curecurrent.com/trials/effects-of-uridine-supplementation-on-metabolic-side-effects-of-stavudine-and-zidovudine-133253https://curecurrent.com/trials/amphotericin-alone-or-in-combination-with-fluconazole-for-aids-associated-meningitis-133254https://curecurrent.com/trials/h1n1-vaccine-at-two-dose-levels-in-hiv-positive-adults-133255https://curecurrent.com/trials/evaluation-of-4-new-simplified-antiretroviral-treatments-in-naive-hiv-1-infected-patients-in-africa-anrs-12115-dayana-133256https://curecurrent.com/trials/study-of-valproic-acid-to-treat-hiv-infected-adults-133257https://curecurrent.com/trials/hla-b35-alleles-and-aids-133258https://curecurrent.com/trials/hiv-resistance-and-treatment-strategies-133259https://curecurrent.com/trials/the-impact-of-short-term-financial-incentives-on-sexual-behavior-and-hiv-incidence-in-lesotho-133260https://curecurrent.com/trials/specialized-cognitive-behavioral-counseling-intervention-to-reduce-hiv-transmission-risk-behavior-in-hiv-infected-men-133261https://curecurrent.com/trials/vaccine-therapy-incomplete-freund-s-adjuvant-and-gm-csf-in-treating-patients-with-hiv-133262https://curecurrent.com/trials/the-safety-and-effectiveness-of-a-two-drug-combination-in-the-treatment-of-patients-with-hepatitis-c-plus-advanced-hiv-i-133263https://curecurrent.com/trials/dolutegravir-renal-impairment-study-133264https://curecurrent.com/trials/evaluation-of-the-performance-of-chembio-diagnostics-systems-inc-dpp-hiv-1-2-rapid-test-133265https://curecurrent.com/trials/trial-of-maraviroc-uk-427-857-in-combination-with-optimized-background-therapy-versus-optimized-background-therapy-alone-133266https://curecurrent.com/trials/a-multiple-ascending-dose-study-of-bms-707035-in-hiv-1-infected-subjects-133267https://curecurrent.com/trials/a-trial-to-evaluate-ad35-grin-env-hiv-vaccine-in-healthy-adult-volunteers-133268https://curecurrent.com/trials/boosted-lexiva-with-lovaza-adjunctive-therapy-in-hypertriglyceridemic-hiv-infected-subjects-133269https://curecurrent.com/trials/comparison-of-liposomal-doxorubicin-used-alone-or-in-combination-with-bleomycin-plus-vincristine-in-the-treatment-of-kap-133270https://curecurrent.com/trials/staying-well-a-clinical-trial-of-mindfulness-based-stress-reduction-and-education-groups-for-hiv-133271https://curecurrent.com/trials/adopting-and-demonstrating-the-adaptation-of-prevention-techniques-community-promise-plus-133272https://curecurrent.com/trials/affect-management-intervention-for-early-adolescents-wtih-mental-health-problems-133273https://curecurrent.com/trials/raltegravir-and-atazanavir-dosing-strategy-study-133274https://curecurrent.com/trials/hiv-infection-and-metabolic-abnormalities-protocol-1-hama001-133275https://curecurrent.com/trials/pk-switch-efavirenz-to-maraviroc-in-patients-initially-suppressed-on-an-efavirenz-containing-regimen-133276https://curecurrent.com/trials/seronegatives-and-metabolic-abnormalities-protocol-2-sama002-study-to-compare-the-effect-of-kaletra-and-combivir-in-hiv-133277https://curecurrent.com/trials/toxicity-substudy-of-evaluation-of-subcutaneous-proleukin-in-a-randomised-international-trial-esprit-toxil-2-substudy-133278https://curecurrent.com/trials/hiv-testing-in-non-traditional-settings-study-133279https://curecurrent.com/trials/hiv-indicator-diseases-survey-across-europe-uk-arm-133280https://curecurrent.com/trials/integration-of-hiv-care-and-treatment-into-antenatal-care-in-migori-district-kenya-133281https://curecurrent.com/trials/methadone-dolutegravir-dtg-gsk1349572-drug-interaction-study-133282https://curecurrent.com/trials/the-pharmacokinetics-of-double-boosted-protease-inhibitors-in-antiretroviral-naive-hiv-1-infected-patients-133283https://curecurrent.com/trials/study-of-genetic-polymorphisms-in-thai-hiv-1-infected-patients-on-sqv-r-133284https://curecurrent.com/trials/housing-and-health-study-133285https://curecurrent.com/trials/adapt-pol-planned-parenthood-center-of-el-paso-adopting-and-demonstrating-the-adaptation-of-prevention-techniques-133286https://curecurrent.com/trials/pharmacokinetics-of-low-dose-ritonavir-133287https://curecurrent.com/trials/influenza-vaccine-in-hiv-infected-children-133288https://curecurrent.com/trials/botswana-pediatric-respiratory-disease-and-bloodstream-infection-study-133289https://curecurrent.com/trials/healthy-volunteer-study-to-assess-the-bioavailability-of-gsk1265744-when-administered-orally-either-when-fasted-or-follo-133290https://curecurrent.com/trials/safety-and-immunogenicity-of-single-dose-choleragarde-in-hiv-seropositive-adults-133291https://curecurrent.com/trials/pharmacokinetics-of-raltegravir-during-third-trimester-pregnancy-and-post-partum-133292https://curecurrent.com/trials/impact-of-peer-health-workers-and-mobile-phones-on-hiv-care-133293https://curecurrent.com/trials/pharmacotherapy-for-hiv-infected-patients-with-alcohol-problems-133294https://curecurrent.com/trials/induction-simplification-with-atazanavir-ritonavir-abacavir-lamivudine-fixed-dose-combination-in-hiv-1-infection-133295https://curecurrent.com/trials/atazanavir-ritonavir-and-zinc-pharmacokinetic-study-133296https://curecurrent.com/trials/examining-the-ability-of-herpes-simplex-virus-type-2-hsv2-therapy-to-reduce-hiv-target-cell-numbers-in-the-cervix-133297https://curecurrent.com/trials/medical-and-economical-impact-of-igras-diagnosis-of-latent-tuberculosis-in-hiv-infected-patients-133298https://curecurrent.com/trials/early-vs-late-introduction-of-antiretroviral-therapy-in-hiv-infected-patients-with-tuberculosis-anrs-1295-camelia-133299https://curecurrent.com/trials/comparison-of-the-shang-ring-with-conventional-surgical-methods-133300https://curecurrent.com/trials/comparing-the-prepex-device-to-surgical-circumcision-for-rapid-scale-up-of-male-circumcision-in-resource-limited-setting-133301https://curecurrent.com/trials/pilot-study-to-determine-the-safety-and-efficacy-of-gardasil-against-the-human-papilloma-virus-hpv-in-hiv-infected-men-133302https://curecurrent.com/trials/testing-an-hiv-prevention-intervention-for-psychiatric-patients-in-brazil-133303https://curecurrent.com/trials/training-community-members-to-deliver-hiv-prevention-programs-to-urban-youth-133304https://curecurrent.com/trials/observational-study-of-effect-of-radiation-therapy-to-immuno-status-in-hiv-cancer-patients-133305https://curecurrent.com/trials/zinc-therapy-in-hiv-infected-individuals-who-abuse-drugs-133306https://curecurrent.com/trials/a-study-of-co-infections-of-hiv-1-and-schistosoma-mansoni-and-its-impact-on-praziquantel-treatment-outcomes-133307https://curecurrent.com/trials/drug-use-investigation-of-kaletra-133308https://curecurrent.com/trials/safety-study-of-txa127-to-elevate-cd4-t-lymphocyte-counts-in-hiv-infected-patients-on-stable-haart-therapy-133309https://curecurrent.com/trials/safety-of-reduced-dose-zidovudine-azt-compared-with-standard-dose-azt-in-antiretroviral-na-ve-hiv-infected-patients-133310https://curecurrent.com/trials/family-to-family-psychoeducation-to-improve-children-s-outcomes-in-hiv-families-133311https://curecurrent.com/trials/phase-iib-pilot-of-atazanavir-raltegravir-133312https://curecurrent.com/trials/the-sasa-study-an-evaluation-of-a-community-intervention-to-address-gender-based-violence-and-reduce-hiv-aids-risk-in-ug-133313https://curecurrent.com/trials/efficacy-of-pegylated-interferon-on-liver-fibrosis-in-co-infected-patient-with-hiv-and-hepatitis-c-133314https://curecurrent.com/trials/observational-study-of-treated-and-untreated-acute-and-early-hiv-1-infection-133315https://curecurrent.com/trials/prospective-evaluation-among-patients-infected-by-hiv-1-in-virological-failure-owing-to-lack-of-compliance-of-the-benefi-133316https://curecurrent.com/trials/comparison-of-nevirapine-and-efavirenz-for-the-treatment-of-hiv-tb-co-infected-patients-anrs-12146-carinemo-133317https://curecurrent.com/trials/universal-use-of-efv-tdf-ftc-and-azt-3tc-lpv-r-combinations-for-hiv-1-pmtct-in-pregnant-and-breastfeeding-women-a-phase-133318https://curecurrent.com/trials/study-comparing-lopinavir-ritonavir-lpv-r-emtricitabine-tenofovir-disoproxil-fumarate-ftc-tdf-with-a-nucleoside-sparing-133319https://curecurrent.com/trials/feasibility-and-pilot-efficacy-of-flash-heated-breast-milk-to-reduce-maternal-to-child-transmission-of-hiv-in-tanzania-133320https://curecurrent.com/trials/study-to-evaluate-the-dosage-and-safety-of-two-intramuscular-injections-of-an-investigational-clade-b-hiv-vaccine-133321https://curecurrent.com/trials/safety-and-pharmacokinetics-of-multiple-rising-oral-doses-of-bi-224436-in-healthy-male-volunteers-133322https://curecurrent.com/trials/optimal-time-to-start-antiretroviral-therapy-in-hiv-infected-adults-with-cryptococcal-meningitis-133323https://curecurrent.com/trials/study-of-lopinavir-ritonavir-tablets-versus-soft-gel-capsules-and-once-daily-versus-twice-daily-administration-when-coad-133324https://curecurrent.com/trials/safety-and-immunogenicity-study-of-candidate-hiv-1-vaccine-given-to-healthy-infants-born-to-hiv-1-2-uninfected-mothers-133325https://curecurrent.com/trials/assessment-of-normal-value-of-acoustic-radiation-force-impulse-arfi-elastography-in-hiv-patients-133326https://curecurrent.com/trials/feasibility-of-a-lateral-flow-urine-lipoarabinomannan-lam-test-for-diagnosis-of-tuberculosis-133327https://curecurrent.com/trials/vaccination-response-in-immunocompromised-host-immune-response-after-vaccination-against-pandemic-a-h1n1-influenza-133328https://curecurrent.com/trials/surveillance-and-medical-help-for-hiv-infected-intravenous-drug-users-in-and-out-of-prison-133329https://curecurrent.com/trials/study-of-the-efficacy-and-safety-of-apricitabine-a-new-nrti-to-treat-drug-resistant-hiv-infection-133330https://curecurrent.com/trials/evaluation-of-interferon-gamma-responses-to-hcmv-infection-in-hiv-positive-individuals-133331https://curecurrent.com/trials/cellular-immune-responses-to-hepatitis-b-virus-hbv-longitudinal-follow-up-and-natural-history-133332https://curecurrent.com/trials/il-7-receptor-polymorphisms-and-immune-recovery-with-haart-133333https://curecurrent.com/trials/impact-of-hiv-and-its-treatment-on-reverse-cholesterol-transport-133334https://curecurrent.com/trials/predictors-of-drug-hypersensitivity-in-hiv-infected-subjects-133335https://curecurrent.com/trials/long-term-immunogenicity-of-quadrivalent-human-papillomavirus-vaccine-gardasil-in-hiv-infected-adolescents-and-young-adu-133336https://curecurrent.com/trials/maraviroc-versus-etravirine-in-combination-with-antiretroviral-therapy-in-drug-experienced-hiv-and-hepatitis-co-infected-133337https://curecurrent.com/trials/hiv-and-std-prevention-for-high-risk-inner-city-african-american-youth-133338https://curecurrent.com/trials/immunogenicity-and-safety-of-a-trivalent-inactivated-influenza-vaccine-formulation-2011-2012-in-dialysis-patients-133339https://curecurrent.com/trials/special-investigation-of-kaletra-in-pregnant-women-133340https://curecurrent.com/trials/measurement-of-adherence-to-art-in-hiv-infected-children-in-uganda-the-charta-study-133341https://curecurrent.com/trials/monitoring-highly-active-antiretroviral-therapy-in-hiv-infected-parents-in-thailand-133342https://curecurrent.com/trials/one-month-dual-antiretroviral-prophylaxis-to-prevent-resistance-mutations-in-mothers-exposed-to-single-dose-nevirapine-133343https://curecurrent.com/trials/reducing-health-problems-associated-with-injection-drug-use-133344https://curecurrent.com/trials/retreatment-with-high-doses-of-pegifn-alfa-2a-and-ribavirin-of-previous-nonresponders-hiv-coinfected-patients-with-cirrh-133345https://curecurrent.com/trials/evaluation-of-a-human-immunodeficiency-virus-hiv-blood-screening-assay-133346https://curecurrent.com/trials/telephone-delivered-behavioral-interventions-to-reduce-risky-sexual-behavior-in-hiv-positive-late-middle-age-and-older-a-133347https://curecurrent.com/trials/therapeutic-intensification-of-hiv-associated-non-hodgkin-s-lymphoma-by-peripheral-blood-cell-transplantation-following-133348https://curecurrent.com/trials/safety-and-efficacy-of-intradermal-injections-of-newfill-versus-eutrophill-in-the-treatment-of-facial-lipoatrophy-in-hiv-133349https://curecurrent.com/trials/a-safety-study-of-a-single-vaginal-administration-of-p2g12-antibody-in-healthy-female-subjects-133350https://curecurrent.com/trials/long-term-effectiveness-and-safety-in-hepatitis-co-infected-patients-133351https://curecurrent.com/trials/couple-oriented-prenatal-hiv-counseling-in-low-and-medium-hiv-prevalence-countries-133352https://curecurrent.com/trials/immunogenicity-and-tolerance-of-two-strategies-of-anti-hav-vaccination-in-hiv-infected-patients-133353https://curecurrent.com/trials/usage-of-acyclovir-for-suppression-of-hiv-1-and-hsv-2-coinfected-persons-in-cameroon-133354https://curecurrent.com/trials/effects-of-an-evidence-service-on-community-based-aids-service-organizations-use-of-research-evidence-133355https://curecurrent.com/trials/evaluation-of-the-public-health-interest-of-kaletra-impact-on-resistance-to-antiretrovirals-arvs-133356https://curecurrent.com/trials/an-expanded-safety-study-of-dapivirine-gel-4789-in-africa-133357https://curecurrent.com/trials/tenofovir-emtricitabine-for-pmtct-in-africa-and-asia-anrs-12109-temaa-133358https://curecurrent.com/trials/once-daily-highly-active-antiretroviral-treatment-regimen-administration-in-hiv-1-infected-children-in-burkina-faso-anrs-133359https://curecurrent.com/trials/efavirenz-based-versus-nevirapine-based-antiretroviral-therapy-among-hiv-infected-patients-receiving-rifampin-133360https://curecurrent.com/trials/once-only-nocturnal-combination-evaluation-of-antiretroviral-experienced-hiv-1-infected-subjects-switching-to-atripla-133361https://curecurrent.com/trials/appropriate-timing-of-haart-in-co-infected-hiv-tb-patients-133362https://curecurrent.com/trials/pharmacokinetics-of-atazanavir-ritonavir-in-hiv-1-infected-pregnant-women-133363https://curecurrent.com/trials/ritonavir-boosted-lopinavir-monotherapy-133364https://curecurrent.com/trials/effectiveness-of-an-hiv-prevention-program-that-targets-the-inner-workings-of-high-risk-social-networks-133365https://curecurrent.com/trials/bioequivalence-study-of-pediatric-formulations-to-treat-hiv-infection-133366https://curecurrent.com/trials/prospective-study-on-hiv-related-hodgkin-lymphoma-133367https://curecurrent.com/trials/efficacy-of-thrice-weekly-directly-observed-treatment-short-course-dots-in-hiv-associated-tuberculosis-133368https://curecurrent.com/trials/safety-and-efficacy-study-of-kp-1461-to-treat-art-experienced-hiv-patients-133369https://curecurrent.com/trials/drug-interaction-study-between-dolutegravir-and-prednisone-133370https://curecurrent.com/trials/ral-eve-study-raltegravir-substitution-study-133371https://curecurrent.com/trials/gemini-study-a-study-of-saquinavir-ritonavir-in-treatment-naive-patients-with-hiv-1-infection-133372https://curecurrent.com/trials/impact-of-maraviroc-on-the-immune-function-in-hiv-1-infected-subjects-receiving-immunisation-with-novel-antigens-133373https://curecurrent.com/trials/etravirine-plus-2-analogs-in-hiv-infected-patients-133374https://curecurrent.com/trials/interactions-between-antiretrovirals-arvs-and-combined-oral-contraceptives-cocs-133375https://curecurrent.com/trials/continuous-use-of-cocs-133376https://curecurrent.com/trials/mk-0518-intensification-and-hdac-inhibition-in-depletion-of-resting-cd4-t-cell-hiv-infection-133377https://curecurrent.com/trials/a-pilot-study-to-characterize-the-pharmacokinetics-of-raltegravir-in-the-cervicovaginal-fluids-of-hiv-infected-women-133378https://curecurrent.com/trials/unboosted-atazanavir-as-initial-art-therapy-in-china-133379https://curecurrent.com/trials/healthy-teen-girls-hiv-risk-reduction-133380https://curecurrent.com/trials/video-based-delivery-of-hiv-test-information-for-spanish-speaking-latinos-133381https://curecurrent.com/trials/clinical-and-experimental-studies-to-improve-radiotherapy-outcome-in-aids-cancer-patients-133382https://curecurrent.com/trials/promoting-safer-sex-in-hiv-homosexual-and-bisexual-men-who-use-methamphetamine-133383https://curecurrent.com/trials/botswana-diarrheal-diseases-study-133384https://curecurrent.com/trials/efficiency-of-the-hepatitis-b-sci-b-vac-vaccine-in-hiv-positive-patients-133385https://curecurrent.com/trials/a-study-on-antiretroviral-therapy-art-na-ve-patients-on-different-regimens-to-treat-hiv-northiv-133386https://curecurrent.com/trials/lovastatin-immunomodulatory-value-evaluation-133387https://curecurrent.com/trials/dimiracetam-in-painful-neuropathies-affecting-aids-patients-133388https://curecurrent.com/trials/evaluation-of-the-safety-of-a-polyvalent-virus-in-healthy-adults-133389https://curecurrent.com/trials/relative-bioavailability-study-of-a-pediatric-granule-formulation-of-dolutegravir-133390https://curecurrent.com/trials/treatment-of-oral-warts-in-hiv-patients-133391https://curecurrent.com/trials/evaluation-of-an-infant-feeding-intervention-for-hiv-exposed-haitian-infants-133392https://curecurrent.com/trials/a-clinical-research-study-designed-to-determine-if-treatment-of-hepatitis-c-with-milk-thistle-is-more-effective-than-no-133393https://curecurrent.com/trials/antiretroviral-treatment-strategies-in-relation-to-adherence-resistance-and-virological-treatment-failure-133394https://curecurrent.com/trials/an-expanded-safety-study-of-dapivirine-gel-4759-in-africa-133395https://curecurrent.com/trials/patient-preference-sleep-quality-and-anxiety-depression-a-randomized-comparison-of-etravirine-and-efavirenz-133396https://curecurrent.com/trials/integrating-buprenorphine-into-the-sfgh-aids-program-133397https://curecurrent.com/trials/a-safety-and-pharmacokinetic-study-for-dapivirine-and-maraviroc-gel-in-belgium-133398https://curecurrent.com/trials/multicenter-safety-study-of-maraviroc-133399https://curecurrent.com/trials/cameroon-mobile-phone-sms-trial-133400https://curecurrent.com/trials/study-of-systemchange-hiv-133401https://curecurrent.com/trials/blood-transfusions-in-thalassemia-patients-complications-and-adverse-effects-133402https://curecurrent.com/trials/pharmacogenetics-of-antiretroviral-drugs-133403https://curecurrent.com/trials/a-pilot-study-of-pre-exposure-prophylaxis-prep-to-evaluate-safety-acceptability-and-adherence-in-at-risk-populations-in-133404https://curecurrent.com/trials/targeting-interventions-at-venues-where-risk-of-hiv-transmission-is-high-133405https://curecurrent.com/trials/safe-drinking-water-for-households-with-infants-born-to-hiv-positive-mothers-pilot-study-133406https://curecurrent.com/trials/integration-of-family-planning-and-hiv-services-in-tanzania-133407https://curecurrent.com/trials/evaluation-of-kaletra-therapy-over-the-long-term-133408https://curecurrent.com/trials/intravaginal-treatment-of-disturbances-of-vaginal-flora-among-hiv-infected-and-uninfected-women-in-malawi-133409https://curecurrent.com/trials/epoetin-alfa-for-hiv-associated-neuropathy-trial-133410https://curecurrent.com/trials/evaluation-of-2-interferon-assays-in-the-diagnosis-of-latent-tuberculosis-in-hiv-infected-patients-anrs-ep-40-quanti-spo-133411https://curecurrent.com/trials/relative-bioavailability-study-of-two-new-dolutegravir-abacavir-lamivudine-fixed-dose-combination-tablets-133412https://curecurrent.com/trials/interleukin-2-plus-antiretroviral-therapy-for-hiv-infected-patients-with-low-cd4-counts-silcaat-study-133413https://curecurrent.com/trials/a-study-of-stavudine-in-hiv-infected-patients-who-have-not-had-success-with-other-anti-hiv-drugs-133414https://curecurrent.com/trials/double-blind-comparison-of-the-efficacy-of-continued-zidovudine-versus-2-3-dideoxyinosine-ddi-bmy-40900-for-the-treatmen-133415https://curecurrent.com/trials/a-comparison-of-zidovudine-azt-and-stavudine-in-hiv-infected-patients-133416https://curecurrent.com/trials/a-study-of-ddi-in-children-with-aids-who-have-not-had-success-with-zidovudine-133417https://curecurrent.com/trials/an-evaluation-of-the-development-of-nevirapine-induced-mutations-in-hiv-patients-initiating-or-discontinuing-combination-133418https://curecurrent.com/trials/a-safety-study-of-dapivirine-vaginal-ring-in-africa-133419https://curecurrent.com/trials/coadministration-of-ezetimibe-with-fenofibrate-versus-pravastatin-monotherapy-for-the-treatment-of-hyperlipidaemia-in-hi-133420https://curecurrent.com/trials/creon-in-hiv-patients-with-steatorrhea-133421https://curecurrent.com/trials/zambia-exclusive-breastfeeding-study-133422https://curecurrent.com/trials/hiv-treatment-and-cvd-events-133423https://curecurrent.com/trials/a-compassionate-access-protocol-for-those-patients-who-have-completed-a4001029-133424https://curecurrent.com/trials/hiv-prevention-and-care-of-psychological-trauma-in-vulnerable-rwandan-youth-133425https://curecurrent.com/trials/a-study-to-determine-the-best-dose-of-antivirals-in-patients-with-both-tb-and-hiv-133426https://curecurrent.com/trials/a-study-of-fuzeon-enfuvirtide-with-an-integrase-inhibitor-plus-optimized-background-in-treatment-experienced-hiv-1-infec-133427https://curecurrent.com/trials/atazanavir-or-boosted-atazanavir-substitution-for-ritonavir-boosted-pi-in-patients-with-hyperlipidemia-133428https://curecurrent.com/trials/safety-and-efficacy-study-comparing-raltegravir-to-a-protease-inhibitor-in-treatment-na-ve-hiv-hepatitis-c-drug-users-133429https://curecurrent.com/trials/comparative-effectiveness-of-web-based-versus-traditional-adolescent-hiv-prevention-133430https://curecurrent.com/trials/safety-study-of-lopinavir-ritonavir-with-raltegravir-in-hiv-infected-patients-133431https://curecurrent.com/trials/lopinavir-capsules-to-kaletra-or-invirase-tablets-133432https://curecurrent.com/trials/evaluation-of-diagnostic-hiv-ag-ab-combo-assay-133433https://curecurrent.com/trials/spatial-epidemiology-of-hiv-infection-133434https://curecurrent.com/trials/topotecan-in-treating-young-patients-with-neoplastic-meningitis-due-to-leukemia-lymphoma-or-solid-tumors-133435https://curecurrent.com/trials/pharmacokinetic-interaction-between-maraviroc-and-fosamprenavir-ritonavir-in-healthy-subjects-133436https://curecurrent.com/trials/a-study-to-investigate-the-pharmacokinetics-safety-and-tolerability-of-gsk1349572-dolutegravir-dtg-in-healthy-japanese-s-133437https://curecurrent.com/trials/tmc278-tidp6-c153-a-study-in-healthy-volunteers-investigating-the-pharmacokinetic-interaction-between-tmc278-and-raltegr-133438https://curecurrent.com/trials/peginterferon-alpha-2a-and-ribavirin-to-treat-hepatitis-c-in-hiv-infected-patients-133439https://curecurrent.com/trials/a-long-term-safety-study-of-apricitabine-in-hiv-infected-patients-133440https://curecurrent.com/trials/pharmacokinetics-of-apricitabine-and-tipranavir-when-dosed-alone-or-together-133441https://curecurrent.com/trials/avx754-a-new-nucleoside-reverse-transcriptase-inhibitor-nrti-to-treat-drug-resistant-hiv-133442https://curecurrent.com/trials/a-long-term-safety-study-of-apricitabine-in-hiv-infected-subjects-133443https://curecurrent.com/trials/a-study-to-investigate-the-cardiovascular-safety-of-apricitabine-in-healthy-subjects-133444https://curecurrent.com/trials/cognitive-behavioral-treatment-to-reduce-alcohol-use-among-hiv-infected-kenyans-133445https://curecurrent.com/trials/evaluation-of-two-anti-hiv-treatment-strategies-in-resource-limited-south-african-communities-133446https://curecurrent.com/trials/pharmacokinetics-of-rifabutin-combined-with-antiretroviral-therapy-in-patients-with-tb-hiv-co-infection-in-south-africa-133447https://curecurrent.com/trials/trial-of-safe-water-storage-among-people-living-with-hiv-133448https://curecurrent.com/trials/safety-and-immunogenicity-study-of-candidate-hiv-1-vaccine-given-to-healthy-infants-born-to-hiv-1-infected-mothers-133449https://curecurrent.com/trials/tmc125-c216-a-phase-iii-study-to-investigate-the-efficacy-tolerability-and-safety-of-tmc125-as-part-of-an-antiretroviral-133450https://curecurrent.com/trials/tb-tuberculosis-preventive-therapy-for-hiv-patients-with-access-to-haart-highly-active-antiretroviral-therapy-133451https://curecurrent.com/trials/tmc114-c213-a-phase-ii-randomized-controlled-partially-blinded-trial-to-investigate-dose-response-of-tmc114-rtv-in-3-cla-133452https://curecurrent.com/trials/a-trial-to-compare-raltegravir-versus-nevirapine-as-anchor-drug-for-hiv-chinese-idus-on-methadone-maintenance-133453https://curecurrent.com/trials/study-of-ngx-4010-for-the-treatment-of-painful-hiv-associated-neuropathy-133454https://curecurrent.com/trials/psychological-morbidity-and-facial-volume-in-hiv-lipodystrophy-quantification-of-treatment-outcome-133455https://curecurrent.com/trials/effects-of-manualized-treatment-in-a-seamless-system-133456https://curecurrent.com/trials/a-study-to-assess-the-effectiveness-of-procrit-epoetin-alfa-dosing-every-2-weeks-versus-once-a-week-in-anemic-hiv-infect-133457https://curecurrent.com/trials/tmc114-c209-a-study-of-safety-of-tmc114-with-low-dose-ritonavir-rtv-and-other-antiretrovirals-in-experienced-hiv-1-infec-133458https://curecurrent.com/trials/a-phase-iia-trial-to-evaluate-the-safety-and-immunogenicity-of-a-dna-hiv-1-vaccine-followed-by-an-mva-hiv-1-vaccine-in-h-133459https://curecurrent.com/trials/bavituximab-repeat-dose-trial-in-patients-co-infected-with-chronic-hepatitis-c-virus-and-human-immunodeficiency-virus-133460https://curecurrent.com/trials/tmc125-tidp2-c197-a-phase-i-trial-to-investigate-the-pharmacokinetic-interaction-between-lopinavir-ritonavir-and-tmc125-133461https://curecurrent.com/trials/tmc125-tidp2-c188-a-phase-i-open-label-trial-to-investigate-the-pharmacokinetic-effect-of-multiple-dose-tmc125-on-bupren-133462https://curecurrent.com/trials/tmc114-tidp3-c181-study-to-assess-the-pharmacokinetics-of-darunavir-drv-with-different-doses-of-ritonavir-in-healthy-vol-133463https://curecurrent.com/trials/tmc125-tidp2-c187-a-phase-i-open-label-trial-to-investigate-the-pharmacokinetic-interaction-between-tmc125-and-two-antif-133464https://curecurrent.com/trials/tmc278-tidp38-c145-a-bioavailability-study-in-healthy-adult-volunteers-to-evaluate-3-pediatric-formulations-of-tmc278-a-133465https://curecurrent.com/trials/safety-and-efficacy-of-t-cell-genetic-immunotherapy-for-hiv-133466https://curecurrent.com/trials/development-of-a-new-hiv-vaccine-133467https://curecurrent.com/trials/a-rollover-study-for-subjects-who-completed-participation-in-the-vrx496-usa-05-002-trial-133468https://curecurrent.com/trials/prospective-epidemiological-study-of-the-prevalence-of-hla-b-5701-in-hiv-1-infected-patients-133469https://curecurrent.com/trials/a-randomised-open-label-trial-to-assess-the-safety-and-efficacy-of-switching-to-tenofovir-emtricitabine-or-abacavir-lami-133470https://curecurrent.com/trials/mefloquine-prophylaxis-in-hiv-1-individuals-a-randomized-placebo-controlled-trial-133471https://curecurrent.com/trials/raltegravir-with-optimized-background-therapy-obt-in-multiple-experienced-hiv-infected-patients-133472https://curecurrent.com/trials/an-open-label-study-to-evaluate-the-effect-of-every-other-week-procrit-epoetin-alfa-dosing-40-000-60-000-units-on-mainta-133473https://curecurrent.com/trials/natural-history-hepatitis-c-virus-human-immunodeficiency-virus-coinfection-133474https://curecurrent.com/trials/tmc125-c211-trial-of-tmc125-in-hiv-1-infected-subjects-who-were-in-a-sponsor-selected-tmc125-trial-133475https://curecurrent.com/trials/tmc114-c201-a-study-to-determine-the-antiviral-activity-of-tmc114-in-patients-with-multiple-protease-inhibitor-pi-resist-133476https://curecurrent.com/trials/tmc125-c227-a-phase-ii-randomized-active-controlled-open-label-trial-to-investigate-the-efficacy-and-tolerability-of-tmc-133477https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-effectiveness-of-epoetin-alfa-in-aids-acquired-immunodeficiency-syndrome-patients-wit-133478https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-effectiveness-of-epoetin-alfa-in-aids-patients-with-anemia-caused-both-by-their-disea-133479https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-epoetin-alfa-versus-placebo-for-the-treatment-of-anemia-in-aids-acquired-133480https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-epoetin-alfa-versus-placebo-for-the-treatment-of-anemia-in-patients-with-133481https://curecurrent.com/trials/safety-and-tolerability-of-multiple-dose-lersivirine-for-21-days-in-healthy-subjects-133482https://curecurrent.com/trials/eurosida-as-an-external-comparator-to-motivate-trials-133483https://curecurrent.com/trials/kaletra-or-lexiva-with-ritonavir-combined-with-epivir-and-abacavir-in-naive-subjects-over-48-weeks-133484https://curecurrent.com/trials/an-open-label-study-to-evaluate-the-safety-and-kinetics-of-nelfinavir-in-subjects-with-hiv-and-hepatitis-c-133485https://curecurrent.com/trials/ketamine-hydrochloride-and-best-pain-management-in-treating-cancer-patients-with-neuropathic-pain-133486https://curecurrent.com/trials/study-in-healthy-males-to-measure-maraviroc-in-blood-saliva-seminal-fluid-and-rectal-tissue-133487https://curecurrent.com/trials/the-effect-of-pregnancy-on-the-pharmacokinetics-of-the-kaletra-tablet-133488https://curecurrent.com/trials/study-in-healthy-males-to-measure-darunavir-and-etravirine-in-blood-seminal-fluid-and-rectal-tissue-133489https://curecurrent.com/trials/capravirine-ag1549-in-combination-with-viracept-and-two-nrtis-in-hiv-infected-patients-who-failed-an-initial-nnrti-conta-133490https://curecurrent.com/trials/bms-reyataz-study-in-treatment-in-naive-subjects-to-compare-the-efficacy-and-safety-between-boosted-reyataz-and-kaletra-133491https://curecurrent.com/trials/study-of-a-potential-preventive-vaccine-against-hiv-in-healthy-volunteers-133492https://curecurrent.com/trials/effectiveness-and-safety-of-two-forms-of-stavudine-in-hiv-infected-patients-133493https://curecurrent.com/trials/a-comparison-of-bms-232632-with-efavirenz-each-in-combination-with-zidovudine-lamivudine-133494https://curecurrent.com/trials/study-of-a-new-protease-inhibitor-bms-232632-in-combination-with-other-anti-hiv-drugs-133495https://curecurrent.com/trials/safety-and-effectiveness-of-a-new-protease-inhibitor-bms-232632-in-hiv-positive-patients-who-have-received-previous-trea-133496https://curecurrent.com/trials/evaluation-of-an-anti-hiv-drug-combination-that-includes-a-coated-form-of-didanosine-ddi-ec-compared-to-a-typical-anti-h-133497https://curecurrent.com/trials/a-comparison-of-atazanavir-and-nelfinavir-each-in-combination-with-2-nrtis-in-patients-who-have-failed-treatments-withou-133498https://curecurrent.com/trials/a-study-to-evaluate-the-use-of-stavudine-d4t-to-treat-aids-dementia-complex-133499https://curecurrent.com/trials/the-safety-and-effectiveness-of-lamivudine-plus-stavudine-or-zidovudine-in-hiv-infected-patients-who-have-taken-zidovudi-133500https://curecurrent.com/trials/predictors-of-neuro-cognitive-decline-and-survival-in-hiv-infected-subjects-133501https://curecurrent.com/trials/qualitative-and-quantitative-hiv-rna-detection-in-saliva-using-the-oragene-rna-kit-133502https://curecurrent.com/trials/acquired-immunodeficiency-syndrome-aids-and-tuberculosis-tb-co-infection-treatment-strategies-study-of-china-133503https://curecurrent.com/trials/safety-of-viracept-625mg-administered-to-hiv-infected-women-during-pregnancy-133504https://curecurrent.com/trials/effect-of-a-non-tenofovir-non-efavirenz-based-hiv-regimen-on-bone-density-and-vitamin-d-levels-in-african-american-patie-133505https://curecurrent.com/trials/dart-ii-a-phase-iv-study-of-3-antiretroviral-medicines-in-combination-in-hiv-patients-who-have-not-been-previously-treat-133506https://curecurrent.com/trials/a-comparison-of-two-triple-drug-combinations-in-patients-who-have-never-been-treated-with-anti-hiv-drugs-133507https://curecurrent.com/trials/switching-hiv-1-infected-subjects-from-a-highly-active-anti-retroviral-treatment-haart-regimen-dosed-twice-daily-or-more-133508https://curecurrent.com/trials/comparison-of-two-anti-hiv-regimens-that-include-one-of-two-forms-of-didanosine-ddi-133509https://curecurrent.com/trials/rollover-study-for-zerit-stavudine-er-studies-096-099-133510https://curecurrent.com/trials/a-comparison-of-two-dose-levels-of-didanosine-used-in-combination-with-stavudine-in-hiv-infected-patients-133511https://curecurrent.com/trials/to-assess-compliance-with-a-once-daily-regimen-of-lamivudine-efavirenz-and-didanosine-133512https://curecurrent.com/trials/dart-i-a-phase-iv-study-of-3-antiretroviral-medicines-in-combination-in-hiv-patients-who-have-not-been-previously-treate-133513https://curecurrent.com/trials/aids-and-cancer-specimen-bank-acsb-133514https://curecurrent.com/trials/study-of-lifestyle-modification-in-hiv-lipodystrophy-133515https://curecurrent.com/trials/study-of-adding-entecavir-to-current-lamivudine-therapy-in-hiv-and-hbv-co-infected-patients-133516https://curecurrent.com/trials/a-study-of-prevalence-of-the-i50l-mutation-when-atv-treated-patients-fail-the-regimen-133517https://curecurrent.com/trials/a-pilot-open-label-trial-of-hiv-therapy-with-d4t-stavudine-ddi-didanosine-nelfinavir-and-hydroxyurea-in-subjects-with-ea-133518https://curecurrent.com/trials/pharmacokinetic-evaluation-of-changes-in-nevirapine-auc-due-to-differences-in-weight-133519https://curecurrent.com/trials/a-study-comparing-two-forms-of-didanosine-in-hiv-infected-patients-133520https://curecurrent.com/trials/atazanavir-for-hiv-infected-individuals-an-early-access-program-133521https://curecurrent.com/trials/a-pilot-study-of-atazanavir-ritonavir-efavirenz-as-a-nucleoside-sparing-regimen-133522https://curecurrent.com/trials/a-phase-iiib-study-evaluating-the-effect-on-serum-lipids-following-a-switch-to-atazanavir-in-hiv-infected-subjects-evide-133523https://curecurrent.com/trials/a-pilot-open-label-trial-of-hiv-therapy-with-d4t-stavudine-ddi-didanosine-nelfinavir-and-hydroxyurea-in-subjects-with-re-133524https://curecurrent.com/trials/drug-interaction-oral-contraceptive-133525https://curecurrent.com/trials/a-pilot-study-to-compare-the-antiviral-and-immunologic-effects-of-stavudine-d4t-versus-placebo-in-subjects-with-evidence-133526https://curecurrent.com/trials/effect-of-the-atazanavir-atv-150l-mutation-on-subsequent-treatment-response-in-hiv-infected-subjects-133527https://curecurrent.com/trials/kivexa-vs-truvada-both-administered-with-efavirenz-in-art-naive-subjects-133528https://curecurrent.com/trials/study-of-lopinavir-ritonavir-tablets-comparing-once-daily-versus-twice-daily-administration-when-coadministered-with-nuc-133529https://curecurrent.com/trials/effect-of-hiv-protease-inhibitor-drugs-on-glucose-and-insulin-metabolism-133530https://curecurrent.com/trials/drug-interaction-study-with-atazanavir-administered-with-and-without-ritonavir-and-a-cytochrome-p450-substrate-rosiglita-133531https://curecurrent.com/trials/atazanavir-and-ritonavir-atv-rtv-and-an-oral-contraceptive-in-healthy-females-133532https://curecurrent.com/trials/dose-finding-confirmation-of-atazanavir-with-ritonavir-and-efavirenz-atv-rtv-efv-in-healthy-subjects-133533https://curecurrent.com/trials/enhancing-hiv-prevention-by-using-behavioral-intervention-among-hiv-infected-men-133534https://curecurrent.com/trials/drug-interaction-study-with-proton-pump-inhibitor-133535https://curecurrent.com/trials/bioequivalence-study-of-atazanavir-300-mg-capsule-133536https://curecurrent.com/trials/atv-ritonavir-nevirapine-interaction-uspac-133537https://curecurrent.com/trials/drug-interaction-study-with-famotidine-atazanavir-and-atazanavir-ritonavir-tenofovir-133538https://curecurrent.com/trials/effect-of-maraviroc-on-the-pharmacokinetics-of-digoxin-133539https://curecurrent.com/trials/atazanavir-twice-daily-133540https://curecurrent.com/trials/the-effects-of-hiv-protease-inhibitors-in-severe-sepsis-133541https://curecurrent.com/trials/lufwanyama-neonatal-survival-project-133542https://curecurrent.com/trials/dating-violence-and-hiv-prevention-in-girls-adapting-mental-health-interventions-133543https://curecurrent.com/trials/pharmacokinetics-of-lopinavir-ritonavir-at-three-different-doses-133544https://curecurrent.com/trials/screening-protocol-to-determine-eligibility-for-studies-of-the-chemokine-coreceptor-5-ccr5-antagonist-gw873140-133545https://curecurrent.com/trials/study-of-chemokine-coreceptor-5-ccr5-antagonist-gw873140-in-r5-x4-tropic-treatment-experienced-hiv-infected-subjects-133546https://curecurrent.com/trials/a-study-of-mva85a-in-asymptomatic-volunteers-infected-with-tb-hiv-or-both-133547https://curecurrent.com/trials/the-safety-and-immunogenicity-of-a-tb-vaccine-mva85a-in-healthy-volunteers-who-are-infected-with-hiv-133548https://curecurrent.com/trials/a-phase-i-study-of-a-new-tuberculosis-tb-vaccine-mva85a-in-healthy-volunteers-with-hiv-133549https://curecurrent.com/trials/a-study-to-compare-three-existing-starting-points-of-anti-retroviral-therapy-art-initiation-in-hiv-tuberculosis-tb-co-in-133550https://curecurrent.com/trials/study-of-cell-phone-sms-messages-for-prevention-of-maternal-to-child-transmission-of-hiv-133551https://curecurrent.com/trials/safety-and-efficacy-of-raltegravir-tdf-3tc-in-hbv-hiv-co-infected-patients-133552https://curecurrent.com/trials/hiv-antiretroviral-drugs-and-metabolism-133553https://curecurrent.com/trials/effectiveness-of-efavirenz-based-regimen-in-hiv-1-infected-patients-with-nevirapine-hypersensitivity-133554https://curecurrent.com/trials/optimal-time-to-initiate-antiretroviral-therapy-in-hiv-tb-coinfected-adults-being-treated-for-tuberculosis-133555https://curecurrent.com/trials/multi-center-comparison-of-fluconazole-uk-49-858-and-amphotericin-b-as-treatment-for-acute-cryptococcal-meningitis-133556https://curecurrent.com/trials/comparison-of-ddi-versus-zidovudine-in-hiv-infected-patients-133557https://curecurrent.com/trials/prevalence-of-hiv-and-tuberculosis-in-masiphumelele-township-cape-town-south-africa-133558https://curecurrent.com/trials/a-study-of-azidothymidine-in-hiv-infected-children-133559https://curecurrent.com/trials/an-efficacy-study-of-2-3-dideoxyinosine-ddi-bmy-40900-administered-orally-twice-daily-to-zidovudine-intolerant-patients-133560https://curecurrent.com/trials/dideoxycytidine-ro-24-2027-a-randomized-open-label-comparative-study-of-dideoxycytidine-ddc-versus-zidovudine-azt-in-pat-133561https://curecurrent.com/trials/ro-24-2027-a-randomized-double-blind-comparative-study-of-dideoxycytidine-ddc-versus-zidovudine-azt-in-patients-with-aid-133562https://curecurrent.com/trials/a-study-of-azidothymidine-plus-methadone-in-patients-with-aids-and-aids-related-complex-arc-133563https://curecurrent.com/trials/a-phase-ii-efficacy-study-comparing-2-3-dideoxyinosine-ddi-bmy-40900-and-zidovudine-therapy-of-patients-with-hiv-infecti-133564https://curecurrent.com/trials/a-multicenter-trial-to-evaluate-oral-retrovir-in-the-treatment-of-children-with-symptomatic-hiv-infection-133565https://curecurrent.com/trials/studies-of-the-ocular-complications-of-aids-soca-cmv-retinitis-trial-foscarnet-ganciclovir-component-133566https://curecurrent.com/trials/a-phase-ii-trial-of-rscd4-and-azt-in-patients-with-aids-or-advanced-aids-related-complex-arc-133567https://curecurrent.com/trials/a-randomized-controlled-study-of-intravenous-ganciclovir-therapy-for-peripheral-cytomegalovirus-retinitis-in-patients-wi-133568https://curecurrent.com/trials/comparison-of-fluconazole-and-amphotericin-b-in-the-treatment-of-brain-infections-in-patients-with-aids-133569https://curecurrent.com/trials/correlating-protection-against-malaria-with-serum-profiles-against-plasmodium-falciparum-antigen-repertoires-133570https://curecurrent.com/trials/a-study-of-an-adherence-plan-to-help-hiv-positive-patients-take-their-first-anti-hiv-medications-correctly-133571https://curecurrent.com/trials/a-study-on-the-rate-of-opportunistic-aids-related-infections-among-hiv-positive-children-who-have-stopped-taking-their-o-133572https://curecurrent.com/trials/effectiveness-of-anti-hiv-drugs-in-patients-who-have-not-received-previous-anti-hiv-drugs-during-different-stages-of-hiv-133573https://curecurrent.com/trials/a-comparison-of-zidovudine-plus-lamivudine-versus-ddi-used-alone-or-in-combination-with-zidovudine-in-hiv-1-infected-chi-133574https://curecurrent.com/trials/metabolism-of-antituberculosis-drugs-in-hiv-infected-persons-with-tuberculosis-133575https://curecurrent.com/trials/effects-on-the-immune-system-of-anti-hiv-drugs-in-patients-recently-infected-with-hiv-133576https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-different-methods-of-birth-control-on-the-drug-actions-of-zidovudine-an-anti-hiv-drug-133577https://curecurrent.com/trials/potent-antiviral-therapy-for-critically-ill-hiv-infected-patients-admitted-to-intensive-care-133578https://curecurrent.com/trials/an-open-label-pilot-study-to-evaluate-the-development-of-resistance-to-nevirapine-bi-rg-587-in-hiv-infected-patients-wit-133579https://curecurrent.com/trials/a-pilot-pharmacokinetic-phase-i-evaluation-of-bi-rg-587-in-hiv-infected-children-133580https://curecurrent.com/trials/the-effects-of-zidovudine-on-the-blood-of-hiv-infected-patients-133581https://curecurrent.com/trials/a-randomized-double-blind-study-of-566c80-versus-septra-sulfamethoxazole-trimethoprim-for-the-treatment-of-pneumocystis-133582https://curecurrent.com/trials/comparing-standard-dose-versus-adjusted-dose-lopinavir-ritonavir-therapy-in-hiv-infected-persons-with-drug-resistance-133583https://curecurrent.com/trials/observational-study-of-the-therapeutic-study-of-recombinant-hiv-1-tat-133584https://curecurrent.com/trials/phase-i-safety-and-immunogenicity-preventative-vaccine-trial-based-on-recombinant-tat-protein-133585https://curecurrent.com/trials/observational-study-of-the-preventive-trial-with-hiv-1-tat-protein-133586https://curecurrent.com/trials/a-study-of-nevirapine-used-alone-or-in-combination-with-azt-in-hiv-1-infected-children-133587https://curecurrent.com/trials/comparison-of-brovavir-versus-acyclovir-in-the-treatment-of-herpes-in-hiv-infected-patients-133588https://curecurrent.com/trials/a-study-of-valacyclovir-hydrochloride-in-the-prevention-of-life-threatening-cytomegalovirus-disease-in-hiv-infected-pati-133589https://curecurrent.com/trials/comparison-of-ro-31-8959-plus-zidovudine-azt-versus-azt-plus-zalcitabine-ddc-versus-ro-31-8959-plus-azt-plus-ddc-133590https://curecurrent.com/trials/phase-i-safety-and-immunogenicity-vaccine-trial-against-hiv-aids-133591https://curecurrent.com/trials/cmv-retinitis-retreatment-trial-133592https://curecurrent.com/trials/vitamin-b-therapy-for-hyperlactatemia-133593https://curecurrent.com/trials/changing-to-nonprotease-inhibitor-treatment-to-improve-side-effects-133594https://curecurrent.com/trials/safety-of-cotrimoxazole-in-hiv-and-haart-exposed-infants-133595https://curecurrent.com/trials/a-phase-ii-safety-and-efficacy-study-of-clarithromycin-in-the-treatment-of-disseminated-m-avium-complex-mac-infections-i-133596https://curecurrent.com/trials/minocycline-for-hiv-cognitive-impairment-in-uganda-133597https://curecurrent.com/trials/clinical-study-of-tuti-16-in-asymptomatic-hiv-1-infected-subjects-133598https://curecurrent.com/trials/comparison-of-two-drugs-cidofovir-and-ganciclovir-in-treating-patients-with-aids-who-have-cmv-retinitis-133599https://curecurrent.com/trials/the-effects-of-prednisone-on-hiv-levels-and-the-immune-system-133600https://curecurrent.com/trials/human-papillomavirus-infection-and-knowledge-and-attitudes-about-hpv-vaccines-among-men-who-have-sex-with-men-msm-133601https://curecurrent.com/trials/efavirenz-and-lamivudine-zidovudine-for-treatment-naive-hiv-infected-people-in-wenxi-county-shanxi-province-china-133602https://curecurrent.com/trials/can-presumptive-anthelminthic-treatment-delay-the-progression-of-hiv-in-art-na-ve-patients-in-rural-africa-133603https://curecurrent.com/trials/safety-of-and-immune-response-to-a-pneumococcal-vaccine-pnccv-in-hiv-infected-and-uninfected-children-133604https://curecurrent.com/trials/characteristics-and-prevalence-of-tuberculosis-and-hiv-in-masiphumelele-township-cape-town-south-africa-133605https://curecurrent.com/trials/reactogenicity-and-immunogenicity-of-vaginal-cngp140-133606https://curecurrent.com/trials/pharmacokinetics-of-lamivudine-at-two-different-doses-133607https://curecurrent.com/trials/pilot-study-evaluating-interruption-of-enfuvirtide-fuzeon-t20-in-patients-with-enfuvirtide-resistance-133608https://curecurrent.com/trials/structured-treatment-interruption-sti-in-acute-primary-hiv-133609https://curecurrent.com/trials/acceptability-study-of-vaginal-films-for-hiv-prevention-133610https://curecurrent.com/trials/plasma-and-intracellular-concentrations-of-raltegravir-and-etravirine-administered-once-daily-133611https://curecurrent.com/trials/estimate-the-effect-of-lersivirine-on-the-pharmacokinetics-of-abacavir-lamivudine-in-healthy-subjects-133612https://curecurrent.com/trials/pharmacokinetic-interaction-between-maraviroc-and-fosamprenavir-ritonavir-in-healthy-subjects-133613https://curecurrent.com/trials/modified-dose-and-schedule-of-recombinant-hepatitis-b-vaccination-in-hiv-infected-adult-subjects-133614https://curecurrent.com/trials/to-determine-the-prevalence-of-hiv-and-other-related-infections-such-as-hepatitis-c-along-with-associated-risk-behaviors-133615https://curecurrent.com/trials/psychiatric-problems-in-children-and-adolescents-infected-with-hiv-at-birth-133616https://curecurrent.com/trials/gene-transfer-for-hiv-using-autologous-t-cells-133617https://curecurrent.com/trials/risk-taking-behaviour-in-msm-and-the-denial-of-sexually-transmitted-diseases-and-hiv-133618https://curecurrent.com/trials/influence-of-nevirapine-on-hcv-viral-load-133619https://curecurrent.com/trials/prevalence-of-hiv-and-other-sexually-transmitted-infections-among-female-sex-workers-and-miners-in-honghe-prefecture-yun-133620https://curecurrent.com/trials/prevalence-of-sexually-transmitted-infections-stis-in-hiv-infected-patients-133621https://curecurrent.com/trials/a-pivotal-study-to-assess-the-safety-and-efficacy-of-the-prepex-system-a-male-circumcision-device-and-methodology-for-ra-133622https://curecurrent.com/trials/compare-to-the-safety-of-efavirenz-and-nevirapine-in-treating-hiv-positive-patients-with-mild-baseline-liver-function-te-133623https://curecurrent.com/trials/effects-of-etravirine-on-endothelial-function-in-hiv-uninfected-adults-a-pilot-study-133624https://curecurrent.com/trials/recovery-management-intervention-in-china-133625https://curecurrent.com/trials/the-effects-of-spirulina-platensis-on-insulin-resistance-in-hiv-infected-patients-133626https://curecurrent.com/trials/a-study-of-acyclovir-to-help-prevent-hiv-infection-in-people-with-genital-herpes-133627https://curecurrent.com/trials/atazanavir-bms-232632-in-combination-with-ritonavir-or-saquinavir-and-lopinavir-ritonavir-each-with-tenofovir-and-a-nucl-133628https://curecurrent.com/trials/efficacy-and-safety-of-switching-from-retrovir-to-tenofovir-or-abacavir-in-hiv-infected-patients-133629https://curecurrent.com/trials/pharmacokinetics-of-emtricitabine-tenofovir-efavirenz-in-hiv-infected-patients-with-tuberculosis-133630https://curecurrent.com/trials/vx-950-tidp24-c124-a-phase-i-trial-to-investigate-the-potential-pharmacokinetic-interactions-between-telaprevir-and-daru-133631https://curecurrent.com/trials/vx-950-tidp24-c134-drug-drug-interaction-trial-between-combination-of-efavirenz-and-tenofovir-disoproxil-fumarate-and-di-133632https://curecurrent.com/trials/immunological-and-viral-response-to-antiretrovirals-in-hiv-patients-with-cd4-cell-count-below-100-133633https://curecurrent.com/trials/dosing-safety-and-pharmacokinetic-profile-of-rifabutin-in-children-receiving-concomitant-treatment-with-kaletra-133634https://curecurrent.com/trials/boost-study-of-increased-dosage-of-lopinavir-ritonavir-lpv-r-133635https://curecurrent.com/trials/trial-of-maraviroc-uk-427-857-in-combination-with-optimized-background-therapy-versus-optimized-background-therapy-alone-133636https://curecurrent.com/trials/drug-interaction-between-coartem-and-nevirapine-efavirenz-or-rifampicin-in-hiv-positive-ugandan-patients-133637https://curecurrent.com/trials/drug-interaction-study-between-lumefantrine-and-lopinavir-ritonavir-133638https://curecurrent.com/trials/antiretroviral-drug-levels-during-and-after-pregnancy-133639https://curecurrent.com/trials/nevirapine-drug-levels-in-hiv-positive-patients-also-receiving-rifampicin-for-tuberculosis-133640https://curecurrent.com/trials/the-shang-ring-a-novel-male-circumcision-device-for-hiv-prevention-133641https://curecurrent.com/trials/depot-contraception-with-and-without-lopinavir-ritonavir-133642https://curecurrent.com/trials/effect-of-extra-virgin-olive-oil-on-atherosclerosis-biomarkers-in-hiv-infected-patients-133643https://curecurrent.com/trials/evaluating-immune-function-tests-in-people-with-hiv-133644https://curecurrent.com/trials/pharmacokinetics-safety-and-toleration-of-maraviroc-administered-to-subjects-with-various-degrees-of-renal-impaired-and-133645https://curecurrent.com/trials/immunology-of-the-infection-perinatal-133646https://curecurrent.com/trials/hiv-prevention-intervention-for-people-living-with-hiv-aids-133647https://curecurrent.com/trials/investigation-of-safety-and-pharmacokinetics-following-a-single-oral-dose-of-300-mg-maraviroc-in-healthy-male-japanese-v-133648https://curecurrent.com/trials/a-safety-and-acceptability-study-of-a-vaginal-ring-microbicide-delivery-method-133649https://curecurrent.com/trials/pharmacokinetic-study-of-indinavir-drug-levels-when-boosted-with-ritonavir-in-thailand-133650https://curecurrent.com/trials/ontogenesis-of-the-p-glycoprotein-in-human-lymphocytes-influence-of-hiv-and-antiretroviral-therapeutics-133651https://curecurrent.com/trials/nutrition-immunology-and-epidemiology-of-tuberculosis-133652https://curecurrent.com/trials/multivitamin-dosage-regimens-in-the-prevention-of-adverse-pregnancy-outcomes-among-hiv-positive-women-133653https://curecurrent.com/trials/trial-of-vitamins-in-hiv-progression-and-transmission-133654https://curecurrent.com/trials/partnership-on-nutrition-and-hiv-aids-research-in-tanzania-exploratory-research-study-on-selenium-and-hiv-infection-133655https://curecurrent.com/trials/pharmacokinetics-pharmacodynamics-and-safety-of-maraviroc-uk-427-857-in-patients-with-human-immunodeficiency-virus-133656https://curecurrent.com/trials/effects-of-food-and-dose-regimen-on-the-antiviral-effects-of-maraviroc-uk-427-857-in-patients-with-human-immunodeficienc-133657https://curecurrent.com/trials/discontinuation-of-antiretroviral-therapy-in-patients-with-asymptomatic-hiv-infection-133658https://curecurrent.com/trials/a-study-of-an-investigational-regimen-combining-fda-approved-hiv-drugs-in-hiv-infected-subjects-133659https://curecurrent.com/trials/a-drug-interaction-study-between-simvastatin-atorvastatin-rosuvastatin-and-gsk2248761-in-healthy-subjects-133660https://curecurrent.com/trials/drug-interaction-study-of-darunavir-ritonavir-and-lopinavir-ritonavir-on-gsk2248761-pk-and-cyp450-probe-drugs-133661https://curecurrent.com/trials/a-bioavailability-study-of-rifabutin-and-lopinavir-ritonavir-in-healthy-adult-subjects-133662https://curecurrent.com/trials/nnrti-pi-toxicity-switch-to-darunavir-study-133663https://curecurrent.com/trials/pk-of-tenofovir-emtricitabine-and-efavirenz-in-healthy-volunteers-133664https://curecurrent.com/trials/adherence-efficacy-and-tolerance-of-once-a-day-nevirapine-based-regimen-in-hiv-1-infected-patients-133665https://curecurrent.com/trials/efavirenz-to-nevirapine-switch-and-low-density-lipoprotein-ldl-dyslipidemia-133666https://curecurrent.com/trials/all-about-youth-evaluation-of-sexual-risk-avoidance-and-risk-reduction-programs-for-middle-school-students-133667https://curecurrent.com/trials/tmc278-tidp15-c150-trial-to-examine-safety-tolerability-and-plasma-pharmacokinetics-of-multiple-doses-of-tmc278la-133668https://curecurrent.com/trials/pegylated-interferon-therapy-for-acute-hepatitis-c-infection-in-hiv-infected-patients-133669https://curecurrent.com/trials/gsk706769-a-first-time-in-human-study-for-males-and-females-133670https://curecurrent.com/trials/a-healthy-volunteer-and-patient-study-to-assess-the-safety-tolerability-and-pharmacokinetics-of-gsk1265744-133671https://curecurrent.com/trials/tenofovir-disoproxil-fumarate-emtricitabine-efavirenz-versus-combivir-efavirenz-in-antiretroviral-naive-hiv-1-infected-s-133672https://curecurrent.com/trials/a-safety-study-to-assess-the-delivery-of-dapivirine-from-a-matrix-vaginal-ring-133673https://curecurrent.com/trials/snap-switching-nucleoside-analogues-protocol-lipoatrophy-and-mitochondrial-function-133674https://curecurrent.com/trials/phase-ii-iii-study-evaluating-the-effect-of-il-2-on-preservation-of-the-cd4-t-lymphocytes-after-interruption-of-antiretr-133675https://curecurrent.com/trials/a-new-tablet-containing-two-fda-approved-drugs-in-hiv-infected-patients-who-have-not-received-prior-therapy-133676https://curecurrent.com/trials/a-study-comparing-safety-of-abacavir-and-lamivudine-administered-once-daily-as-a-single-tablet-versus-the-same-drugs-adm-133677https://curecurrent.com/trials/drug-interaction-study-between-rifabutin-and-lersivirine-uk-453-061-133678https://curecurrent.com/trials/clinical-trial-to-assess-the-efficacy-of-darunavir-ritonavir-drv-r-etravirine-etv-and-raltegravir-mk-0518-in-hiv-patient-133679https://curecurrent.com/trials/pharmacokinetics-of-efavirenz-in-hiv-1-infected-subjects-with-hepatic-impairment-133680https://curecurrent.com/trials/efficacy-and-safety-of-raltegravir-ral-in-treatment-experienced-hiv-1-infected-adult-chinese-patients-133681https://curecurrent.com/trials/comparative-evaluation-of-the-safety-and-the-efficacy-of-2-antimalarials-depending-on-hiv-status-133682https://curecurrent.com/trials/ipt-of-malaria-with-sp-in-different-zones-of-drug-resistance-in-rwanda-133683https://curecurrent.com/trials/gsk1349572-drug-interaction-study-with-protease-inhibitors-133684https://curecurrent.com/trials/atazanavir-versus-lopinavir-ritonavir-lpv-rtv-in-patients-who-have-not-had-success-with-protease-inhibitor-containing-ha-133685https://curecurrent.com/trials/the-effect-of-lersivirine-uk-453-061-on-qt-intervals-in-healthy-subjects-133686https://curecurrent.com/trials/a-study-of-patients-who-develop-hiv-infection-after-enrolling-in-hiv-vaccine-trials-or-hiv-vaccine-preparedness-trials-133687https://curecurrent.com/trials/ddi-study-of-etravirine-and-gsk1265744-133688https://curecurrent.com/trials/micronutrients-and-enteric-infections-in-african-children-133689https://curecurrent.com/trials/tb-nutrition-immunology-and-epidemiology-133690https://curecurrent.com/trials/a-trial-of-pehrg214-in-hiv-infected-patients-133691https://curecurrent.com/trials/atazanavir-ritonavir-and-darunavir-ritonavir-pk-tail-study-133692https://curecurrent.com/trials/pre-exposure-prophylaxis-using-tmc278la-133693https://curecurrent.com/trials/raltegravir-insulin-sensitivity-study-133694https://curecurrent.com/trials/double-protease-inhibitor-to-darunavir-switch-study-133695https://curecurrent.com/trials/maraviroc-300-mg-twice-daily-in-hiv-negative-male-volunteers-133696https://curecurrent.com/trials/raltegravir-and-ezetimibe-pk-study-133697https://curecurrent.com/trials/anti-hiv-drugs-for-ugandan-patients-with-hiv-and-tuberculosis-133698https://curecurrent.com/trials/a-pilot-study-of-pre-exposure-prophylaxis-prep-to-evaluate-safety-acceptability-and-adherence-in-at-risk-populations-in-133699https://curecurrent.com/trials/effectiveness-study-low-dose-naltrexone-versus-arv-s-for-hiv-133700https://curecurrent.com/trials/rocket-i-randomized-open-label-switch-for-cholesterol-elevation-on-kivexa-evaluation-trial-133701https://curecurrent.com/trials/evaluation-of-the-efficacy-of-hydroxychloroquine-in-decreasing-immune-activation-in-asymptomatic-hiv-infected-patients-133702https://curecurrent.com/trials/prognosis-of-acute-coronary-syndrome-in-hiv-infected-patients-133703https://curecurrent.com/trials/impact-of-nutrition-intervention-on-hiv-aids-infected-patients-133704https://curecurrent.com/trials/physiologic-growth-hormone-effects-in-hiv-lipodystrophy-133705https://curecurrent.com/trials/hiv-aids-kaposis-sarcoma-comparison-of-response-to-haart-vs-haart-plus-cxt-133706https://curecurrent.com/trials/phase-iiib-study-to-evaluate-the-effectiveness-and-safety-of-atazanavir-ritonavir-as-single-enhanced-protease-inhibitor-133707https://curecurrent.com/trials/7-valent-pneumococcal-conjugated-vaccination-133708https://curecurrent.com/trials/hiv-testing-in-the-emergency-department-at-baystate-medical-center-a-pilot-program-133709https://curecurrent.com/trials/to-evaluate-effectiveness-and-safety-of-containing-raltegravir-in-naive-hiv-non-b-or-b-infected-patients-133710https://curecurrent.com/trials/using-drug-levels-in-the-blood-to-guide-therapy-in-hiv-infected-patients-taking-a-protease-inhibitor-133711https://curecurrent.com/trials/tmc278-tidp6-c154-evaluation-of-the-possible-influence-of-omeprazole-intake-and-the-ph-increase-in-the-stomach-triggered-133712https://curecurrent.com/trials/safety-and-efficacy-of-rescriptor-in-patients-for-human-immunodeficiency-virus-hiv-patients-133713https://curecurrent.com/trials/pharmacokinetic-interaction-between-the-antimalarial-combination-artemether-lumefantrine-and-combination-antiretroviral-133714https://curecurrent.com/trials/artemether-lumefantrine-and-nevirapine-interaction-study-in-hiv-infected-adults-133715https://curecurrent.com/trials/metabolic-safety-of-raltegravir-versus-darunavir-in-hiv-naive-patients-133716https://curecurrent.com/trials/molecular-biology-of-anal-cancer-in-hiv-positive-patients-133717https://curecurrent.com/trials/evaluation-of-many-men-many-voices-an-std-hiv-prevention-intervention-for-black-msm-133718https://curecurrent.com/trials/improving-sleep-and-quality-of-life-in-adults-with-hiv-disease-133719https://curecurrent.com/trials/biomarkers-of-insomnia-and-fatigue-in-hiv-aids-symptoms-and-genetics-study-133720https://curecurrent.com/trials/cell-phone-intervention-to-support-antiretroviral-therapy-art-adherence-in-kenya-133721https://curecurrent.com/trials/a-study-to-assess-the-long-term-efficacy-24-weeks-of-mpc-4326-in-combination-with-a-2-3-drug-obr-relative-to-the-efficac-133722https://curecurrent.com/trials/preventing-progression-of-adipose-tissue-redistribution-133723https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-aids-related-hodgkin-s-disease-133724https://curecurrent.com/trials/basic-boosted-atazanavir-or-saquinavir-induced-lipid-changes-133725https://curecurrent.com/trials/dermal-hiv-1-immunization-during-anti-retroviral-therapy-followed-by-repeated-treatment-interruptions-133726https://curecurrent.com/trials/abacavir-lamivudine-versus-emtricitabine-tenofovir-both-in-combination-with-lopinavir-ritonavir-for-the-treatment-of-hiv-133727https://curecurrent.com/trials/hbv-specific-t-cell-immunity-in-individuals-with-hiv-hbv-co-infection-133728https://curecurrent.com/trials/the-core-buprenorphine-project-an-hiv-primary-care-program-demonstration-133729https://curecurrent.com/trials/hepatitis-b-vaccination-in-hiv-infected-persons-133730https://curecurrent.com/trials/safety-and-preliminary-evidence-of-efficacy-of-escalating-doses-of-dimiracetam-in-aids-patients-with-painful-neuropathy-133731https://curecurrent.com/trials/free-study-efficacy-and-toxicity-of-trizivir-133732https://curecurrent.com/trials/peroral-supplemental-nutrition-in-end-stage-renal-disease-with-and-without-hiv-comorbidity-133733https://curecurrent.com/trials/study-to-identify-and-characterize-bacteria-causing-acute-otitis-media-in-south-african-children-133734https://curecurrent.com/trials/phase-i-safety-study-of-a-recombinant-mva-hiv-multiantigen-vaccine-in-hiv-infected-subjects-133735https://curecurrent.com/trials/low-dose-peginterferon-2a-for-chronic-hepatitis-c-genotypes-2-or-3-in-hiv-coinfected-patients-133736https://curecurrent.com/trials/evaluation-of-the-healthy-love-workshop-an-hiv-prevention-intervention-for-african-american-women-133737https://curecurrent.com/trials/hiv-prevention-preparedness-study-133738https://curecurrent.com/trials/cardiovascular-diseases-in-hiv-infected-subjects-hiv-heart-study-133739https://curecurrent.com/trials/injecting-drug-use-community-intervention-trial-133740https://curecurrent.com/trials/study-of-reyataz-in-hiv-infected-patients-with-lipodystrophy-syndrome-133741https://curecurrent.com/trials/a-new-telemedicine-approach-for-chronic-hiv-aids-patient-home-care-133742https://curecurrent.com/trials/tuberculosis-and-human-immunodeficiency-virus-hiv-immune-reconstitution-syndrome-trial-thirst-133743https://curecurrent.com/trials/integrating-family-planning-into-postabortion-care-133744https://curecurrent.com/trials/tmc278-tidp6-c136-effect-of-tmc278-on-ethinylestradiol-and-norethindrone-in-healthy-women-133745https://curecurrent.com/trials/innovation-tifp4-c101-a-study-to-evaluate-the-pharmacokinetics-of-tmc114-and-tmc41629-after-a-single-oral-dose-of-2-cont-133746https://curecurrent.com/trials/tmc278-tidp6-c130-pharmacokinetics-safety-and-tolerability-of-tmc278-in-subjects-with-mildly-or-moderately-impaired-hepa-133747https://curecurrent.com/trials/tmc278-tidp6-c121-drug-drug-interaction-trial-to-investigate-the-potential-interaction-between-tmc278-25-mg-daily-and-me-133748https://curecurrent.com/trials/tmc125-c203-phase-ii-randomized-patients-are-assigned-different-treatments-based-on-chance-placebo-controlled-dose-escal-133749https://curecurrent.com/trials/pepi-tidp23-c103-first-in-human-study-to-examine-the-safety-tolerability-and-plasma-pharmacokinetics-of-increasing-singl-133750https://curecurrent.com/trials/tmc125-c223-tmc125-in-hiv-1-infected-subjects-133751https://curecurrent.com/trials/tmc114-c227-a-study-to-evaluate-the-effectiveness-and-safety-of-tmc114-darunavir-with-a-low-dose-of-ritonavir-as-monothe-133752https://curecurrent.com/trials/long-term-effects-of-haart-in-youth-with-stronger-immune-systems-versus-youth-with-weaker-immune-systems-133753https://curecurrent.com/trials/breastfeeding-antiretroviral-and-nutrition-study-133754https://curecurrent.com/trials/acupressure-to-treat-nausea-and-vomiting-in-hiv-aids-patients-133755https://curecurrent.com/trials/study-of-home-based-resistance-and-strength-training-in-hiv-infected-women-133756https://curecurrent.com/trials/pharmacotherapy-for-hiv-stimulant-dependent-individuals-133757https://curecurrent.com/trials/androgen-effects-in-hiv-infected-women-133758https://curecurrent.com/trials/men-who-have-sex-with-men-msm-community-intervention-trial-133759https://curecurrent.com/trials/a-study-to-investigate-the-clearance-of-pf-04776548-from-the-body-following-a-very-low-micro-dose-of-the-compound-using-133760https://curecurrent.com/trials/switching-from-pi-to-raltegravir-in-hiv-stable-patients-133761https://curecurrent.com/trials/integrase-resistance-analysis-in-hiv-patients-who-interrupted-raltegravir-due-to-incomplete-viral-suppression-133762https://curecurrent.com/trials/atazanavir-or-lopinavir-in-hiv-post-exposure-prophylaxis-133763https://curecurrent.com/trials/effectiveness-of-directly-observed-therapy-in-combined-hiv-and-tuberculosis-treatment-in-resource-limited-settings-133764https://curecurrent.com/trials/observing-patients-with-early-hiv-infection-133765https://curecurrent.com/trials/reducing-hiv-risk-among-mexican-youth-133766https://curecurrent.com/trials/comparison-of-concentration-time-course-of-plasma-and-intracellular-raltegravir-in-healthy-volunteers-133767https://curecurrent.com/trials/project-icare-intervening-for-community-awareness-respect-empowerment-133768https://curecurrent.com/trials/proyecto-sol-a-risk-reduction-intervention-for-hispanic-men-who-have-sex-with-men-msm-133769https://curecurrent.com/trials/culturally-tailored-hiv-risk-reduction-for-african-american-msm-133770https://curecurrent.com/trials/metabolic-effects-of-switching-kaletra-to-boosted-reyataz-133771https://curecurrent.com/trials/antiviral-activity-and-safety-of-mifepristone-at-2-doses-in-hiv-1-infected-subjects-133772https://curecurrent.com/trials/no-excuses-sin-buscar-excusas-intervention-to-reduce-latino-men-s-hiv-risks-133773https://curecurrent.com/trials/novel-rinse-to-treat-in-oral-candidiasis-in-cancer-patients-133774https://curecurrent.com/trials/study-of-boosted-atazanavir-atv-versus-non-boosted-atv-in-naive-patients-133775https://curecurrent.com/trials/a-study-to-determine-how-and-why-hiv-infected-subjects-on-anti-viral-treatment-develop-lipodystrophy-133776https://curecurrent.com/trials/trial-of-cognitive-behavioral-therapy-to-reduce-antiretroviral-therapy-side-effects-133777https://curecurrent.com/trials/polyacrylamide-hydrogel-injection-in-hiv-related-lipoatrophy-133778https://curecurrent.com/trials/vaccine-responses-to-influenza-a-h1n1-09-immunization-in-high-risk-patients-133779https://curecurrent.com/trials/pioglitazone-to-treat-fatty-liver-in-people-with-hiv-infection-133780https://curecurrent.com/trials/study-switching-hiv-1-infected-patients-with-an-undetectable-viral-load-on-a-first-protease-inhibitor-based-regimen-to-a-133781https://curecurrent.com/trials/study-of-the-hiv-gp120-neftat-as02a-vaccine-to-treat-individuals-with-chronic-hiv-1-infection-on-highly-active-antiretro-133782https://curecurrent.com/trials/aids-wasting-in-women-anabolic-effects-of-testosterone-133783https://curecurrent.com/trials/lopinavir-ritonavir-or-efavirenz-as-first-line-antiretroviral-therapy-133784https://curecurrent.com/trials/maraviroc-celsentri-with-raltegravir-and-darunavir-ritonavir-for-the-treatment-of-triple-class-failure-in-adult-hiv-1-in-133785https://curecurrent.com/trials/effect-of-soluble-fiber-on-hypertriglyceridemia-and-immune-profile-in-hiv-positive-individuals-133786https://curecurrent.com/trials/a-pilot-study-of-the-effect-of-minocycline-on-cerebrospinal-fluid-hiv-1-infection-133787https://curecurrent.com/trials/drug-interaction-study-of-famotidine-and-atazanavir-with-ritonavir-in-hiv-infected-patients-133788https://curecurrent.com/trials/study-of-hiv-patients-with-undetectable-viral-load-and-abnormal-lipids-switching-to-atazanavir-ritonavir-133789https://curecurrent.com/trials/a-phase-iiib-study-comparing-two-boosted-protease-inhibitor-based-haart-regimens-in-hiv-infected-patients-experiencing-t-133790https://curecurrent.com/trials/raltegravir-treatment-in-patients-failing-highly-active-antiretroviral-therapy-haart-in-denmark-133791https://curecurrent.com/trials/ddi-hv-atv-merck-133792https://curecurrent.com/trials/tenofovir-df-disoproxil-fumarate-in-combination-with-emtricitabine-in-hiv-1-patients-133793https://curecurrent.com/trials/the-impact-of-short-message-services-sms-on-arv-adherence-in-western-kenya-133794https://curecurrent.com/trials/a-comparison-of-virco-type-hiv-1-testing-versus-expert-interpretation-of-genotypic-results-for-control-of-hiv-1-replicat-133795https://curecurrent.com/trials/clinical-utility-of-genetic-screening-for-hla-b-5701-on-susceptibility-to-abacavir-hypersensitivity-133796https://curecurrent.com/trials/phase-2-safety-and-efficacy-study-of-bevirimat-functional-monotherapy-in-hiv-treatment-experienced-patients-for-2-weeks-133797https://curecurrent.com/trials/totem-switch-from-other-nucleoside-reverse-transcriptase-inhibitors-nrtis-to-once-daily-truvada-133798https://curecurrent.com/trials/the-effect-of-vitamin-d-and-calcium-on-bone-in-pediatric-hiv-133799https://curecurrent.com/trials/nutrition-intervention-in-aids-wasting-133800https://curecurrent.com/trials/pharmacokinetics-pk-study-of-once-daily-darunavir-ritonavir-and-twice-and-once-daily-raltegravir-in-hiv-infected-subject-133801https://curecurrent.com/trials/patient-preference-sleep-quality-and-anxiety-depression-a-comparison-of-raltegravir-and-efavirenz-133802https://curecurrent.com/trials/induction-maintenance-with-atazanavir-in-hiv-na-ve-patients-the-induma-study-133803https://curecurrent.com/trials/study-of-uc-781-vaginal-microbicide-133804https://curecurrent.com/trials/safety-and-efficacy-study-of-mpc-4326-for-treatment-of-patients-with-hiv-1-infection-133805https://curecurrent.com/trials/triomune-bioequivalence-with-innovators-133806https://curecurrent.com/trials/safety-and-acceptability-of-pro-2000-vaginal-gel-in-hiv-uninfected-women-in-india-133807https://curecurrent.com/trials/exercise-for-patients-with-hiv-infections-133808https://curecurrent.com/trials/the-neuropsychiatric-evaluation-of-hiv-positive-and-negative-drug-using-individuals-study-215-133809https://curecurrent.com/trials/rosiglitazone-avandia-treatment-in-hiv-its-effect-on-blood-vessels-133810https://curecurrent.com/trials/correlation-between-cytokines-and-hepatic-histology-in-patients-infected-by-hiv-1-and-the-hepatitis-c-virus-133811https://curecurrent.com/trials/efficacy-study-of-t-cell-vaccination-in-hiv-infection-133812https://curecurrent.com/trials/immunogenicity-and-safety-of-2-schedules-of-alvac-hiv-vcp1452-in-chronically-hiv-infected-patients-133813https://curecurrent.com/trials/a-comparison-of-two-ways-to-manage-anti-hiv-treatment-the-smart-study-133814https://curecurrent.com/trials/safety-study-comparing-a-vaccine-transcutaneous-administration-to-the-intramuscular-route-133815https://curecurrent.com/trials/linfotargam-treatment-with-chemotherapy-plus-rituximab-and-highly-active-antiretroviral-therapy-in-patients-with-diffuse-133816https://curecurrent.com/trials/pilot-trial-of-a-synbiotic-in-hiv-patients-133817https://curecurrent.com/trials/pilot-study-switching-individuals-receiving-efv-with-continuing-central-nervous-system-toxicity-to-tmc125-133818https://curecurrent.com/trials/abacavir-pharmacokinetic-study-in-the-absence-presence-of-darunavir-ritonavir-or-raltegravir-in-hiv-infected-subjects-133819https://curecurrent.com/trials/cardiovascular-risk-evaluation-and-antiretrovirals-in-hiv-133820https://curecurrent.com/trials/reassessment-of-the-nutritional-status-in-thai-orphans-living-with-hiv-in-a-family-style-community-133821https://curecurrent.com/trials/conjugate-and-polysaccharide-vaccines-compared-with-polysaccharide-vaccine-in-hiv-infected-adults-133822https://curecurrent.com/trials/characterization-of-the-adherence-threshold-for-hiv-suppression-of-a-kaletra-based-regimen-133823https://curecurrent.com/trials/induction-and-expansion-of-t-cell-repertoire-using-growth-hormone-and-vaccination-in-hiv-1-infected-patients-133824https://curecurrent.com/trials/a-study-of-peer-education-to-prevent-hiv-transmission-among-injection-drug-users-and-their-hiv-risk-contacts-133825https://curecurrent.com/trials/preliminary-study-of-early-primary-hiv-infection-in-a-high-risk-cohort-133826https://curecurrent.com/trials/profile-of-hiv-seropositive-patients-133827https://curecurrent.com/trials/research-on-effect-of-traditional-chinese-medicine-tcm-on-immune-reconstitution-of-hiv-aids-patients-after-highly-active-133828https://curecurrent.com/trials/the-effect-of-combination-of-traditional-chinese-medicine-tcm-and-highly-active-antiretroviral-therapy-haart-on-immune-r-133829https://curecurrent.com/trials/qol-and-adherence-to-one-pill-once-a-day-haart-133830https://curecurrent.com/trials/clinical-trials-on-the-effect-of-immunity-1-fuzheng-1-on-immune-reconstitution-of-hiv-patients-133831https://curecurrent.com/trials/antiretroviral-switch-from-didanosine-to-tenofovir-in-hiv-hcv-co-infected-patients-133832https://curecurrent.com/trials/gsk1349572-proton-pump-inhibitor-drug-interaction-and-supratherapeutic-dose-study-133833https://curecurrent.com/trials/safety-and-efficacy-of-two-once-daily-anti-retroviral-treatment-regimens-along-with-anti-tuberculosis-treatment-133834https://curecurrent.com/trials/italian-prospective-data-collection-for-better-patient-characterization-in-a-highly-treatment-experienced-population-133835https://curecurrent.com/trials/cd4-cell-recovery-in-hiv-1-patients-comparing-2-treatment-regimes-133836https://curecurrent.com/trials/evaluation-of-effectiveness-of-pharmaceutical-care-on-the-adherence-of-hiv-positive-patients-to-antiretroviral-therapy-133837https://curecurrent.com/trials/anatomic-and-visual-function-assessments-on-asymptomatic-hiv-positive-patients-133838https://curecurrent.com/trials/genotypic-resistant-hiv-strains-in-taiwan-133839https://curecurrent.com/trials/video-based-counseling-rapid-hiv-testing-for-teens-133840https://curecurrent.com/trials/ganciclovir-implant-study-for-cytomegalovirus-retinitis-133841https://curecurrent.com/trials/sequential-hiv-therapy-in-treatment-resistant-hiv-1-infected-patients-133842https://curecurrent.com/trials/evaluation-of-opt-out-rapid-hiv-testing-in-the-emergency-department-133843https://curecurrent.com/trials/impact-of-hiv-infection-on-latent-tuberculosis-tb-among-patients-with-hiv-tb-co-infection-133844https://curecurrent.com/trials/simplification-from-protease-inhibitors-to-raltegravir-133845https://curecurrent.com/trials/pilot-study-of-patients-chronic-hepatitis-c-in-co-infected-hiv-patients-relapsers-after-previous-therapies-133846https://curecurrent.com/trials/effectiveness-of-inpatient-voluntary-counseling-and-testing-vct-in-uganda-133847https://curecurrent.com/trials/feasibility-study-of-a-vaginal-ring-for-delivery-of-tmc120-dapivirine-133848https://curecurrent.com/trials/a-safety-study-of-dapivirine-tmc120-vaginal-microbicide-gel-in-belgium-133849https://curecurrent.com/trials/safety-and-feasibility-study-of-dapivirine-tmc120-vaginal-ring-in-belgium-133850https://curecurrent.com/trials/a-pharmacokinetic-study-of-dapivirine-vaginal-rings-in-belgium-133851https://curecurrent.com/trials/study-of-patients-with-strongyloides-stercoralis-infection-133852https://curecurrent.com/trials/effectiveness-of-rosuvastatin-at-preventing-the-progression-of-atherosclerosis-in-hiv-positive-patients-133853https://curecurrent.com/trials/vitamins-breastmilk-hiv-shedding-and-child-health-133854https://curecurrent.com/trials/trial-of-vitamins-among-children-of-hiv-infected-women-133855https://curecurrent.com/trials/energy-specific-far-infrared-radiation-treatment-for-aids-133856https://curecurrent.com/trials/growth-hormone-to-increase-immune-function-in-people-with-hiv-133857https://curecurrent.com/trials/preparing-for-adolescent-hiv-vaccine-trials-in-south-africa-133858https://curecurrent.com/trials/exercise-oxidative-stress-and-hiv-133859https://curecurrent.com/trials/safety-and-efficacy-of-adaptavir-s-ability-to-eliminate-treatment-resistant-infectious-virus-in-peripheral-blood-mononuc-133860https://curecurrent.com/trials/safety-and-tolerability-of-pegylated-interferon-peg-ifn-alfa-2a-in-hiv-infected-people-133861https://curecurrent.com/trials/using-the-drug-thalidomide-to-stimulate-t-cells-in-hiv-infected-people-133862https://curecurrent.com/trials/the-effect-of-alendronate-calcium-and-vitamin-d-on-bone-mineral-density-in-hiv-infected-patients-133863https://curecurrent.com/trials/nevirapine-nvp-use-to-prevent-mother-to-child-transmission-of-hiv-133864https://curecurrent.com/trials/zidovudine-levels-in-hiv-infected-patients-being-treated-for-hcv-133865https://curecurrent.com/trials/adjusting-antiretroviral-therapy-dosage-using-therapeutic-drug-monitoring-133866https://curecurrent.com/trials/safety-and-efficacy-study-of-etanercept-enbrel-on-the-response-rate-of-hiv-infected-subjects-133867https://curecurrent.com/trials/mycophenolate-mofetil-in-antiretroviral-na-ve-patients-2-man2-study-133868https://curecurrent.com/trials/effects-of-mycophenolate-mofetil-mmf-on-surrogate-markers-for-cardiovascular-disease-in-hiv-1-infected-patients-133869https://curecurrent.com/trials/single-blind-controlled-safety-and-immunogenicity-study-of-recombinant-mva-virus-to-treat-hiv-infection-133870https://curecurrent.com/trials/a-48-week-randomised-study-to-describe-the-pharmacokinetic-profile-and-durability-of-atazanavir-saquinavir-ritonavir-onc-133871https://curecurrent.com/trials/a-study-on-the-safety-and-anti-hiv-activity-of-he2000-in-hiv-infected-patients-on-salvage-therapy-133872https://curecurrent.com/trials/diagnosis-of-primary-aldosteronism-comparison-of-post-captopril-active-renin-concentration-and-plasma-renin-activity-133873https://curecurrent.com/trials/safety-and-antifungal-activity-of-recombinant-interferon-gamma-1b-rifn-gamma-1b-given-with-standard-therapy-in-patients-133874https://curecurrent.com/trials/glutathione-and-its-precursors-in-hiv-infected-patients-133875https://curecurrent.com/trials/effect-of-atazanavir-on-endothelial-function-in-hiv-infected-patients-133876https://curecurrent.com/trials/interactions-of-hepatitis-c-viral-hcv-dynamics-and-immune-activation-in-hiv-coinfected-patients-during-hcv-treatment-133877https://curecurrent.com/trials/chemokine-coreceptor-5-ccr5-antagonist-gw873140-in-r5-tropic-treatment-experienced-hiv-infected-subjects-133878https://curecurrent.com/trials/hla-b-5701-and-hypersensitivity-to-abacavir-133879https://curecurrent.com/trials/observational-study-of-hiv-infected-subjects-with-x4-tropic-or-non-phenotypeable-virus-133880https://curecurrent.com/trials/cognitive-and-psychosocial-benefits-of-misc-training-for-ugandan-children-133881https://curecurrent.com/trials/safety-and-acceptability-study-of-the-uc-781-microbicide-gel-applied-rectally-133882https://curecurrent.com/trials/effect-of-male-circumcision-on-hiv-incidence-anrs-1265-133883https://curecurrent.com/trials/62-15-ethanol-in-emollient-gel-as-topical-male-microbicides-133884https://curecurrent.com/trials/vaccination-with-autologous-dendritic-cells-pulsed-with-hiv-antigens-for-treatment-of-patients-with-chronic-hiv-infectio-133885https://curecurrent.com/trials/safety-study-of-the-hemomodulator-system-for-the-treatment-of-patients-with-human-immunodeficiency-virus-hiv-133886https://curecurrent.com/trials/facial-lipoatrophy-trial-immediate-versus-deferred-injections-of-poly-l-lactic-acid-for-hiv-facial-lipoatrophy-133887https://curecurrent.com/trials/gmb-study-of-truvada-tdf-ftc-or-emtricitabine-ftc-alone-versus-haart-interruption-in-hiv-infected-patients-with-resistan-133888https://curecurrent.com/trials/study-on-the-antiviral-therapy-and-immune-reconstitution-of-chinese-hiv-aids-patients-133889https://curecurrent.com/trials/effect-of-omacor-on-triglycerides-in-hiv-infected-subjects-133890https://curecurrent.com/trials/hiv-assessment-in-fuyang-anhui-province-china-133891https://curecurrent.com/trials/a-phase-i-pharmacokinetics-and-safety-study-of-two-dapivirine-intravaginal-gels-133892https://curecurrent.com/trials/a-cluster-randomized-intervention-trial-to-improve-quality-of-life-for-hiv-infected-individuals-in-anhui-china-133893https://curecurrent.com/trials/genetics-of-progressive-multifocal-leukoencephalopathy-and-acquired-immunodeficiency-syndrome-133894https://curecurrent.com/trials/study-of-impacts-of-food-supplementation-on-malnourished-hiv-infected-adults-in-kenya-133895https://curecurrent.com/trials/arginine-as-an-adjuvant-treatment-against-tuberculosis-133896https://curecurrent.com/trials/stress-reducing-interventions-in-hiv-patients-pilot-133897https://curecurrent.com/trials/phase-i-study-of-safety-and-persistence-of-uc-781-vaginal-microbicide-133898https://curecurrent.com/trials/effective-aids-treatment-and-support-in-the-free-state-feats-133899https://curecurrent.com/trials/co-administration-of-fosamprenavir-with-methadone-a-drug-interaction-study-133900https://curecurrent.com/trials/a-study-to-compare-two-anti-hiv-drug-combinations-in-hiv-infected-patients-who-have-previously-received-anti-hiv-treatme-133901https://curecurrent.com/trials/a-study-of-abt-378-ritonavir-combination-in-hiv-infected-patients-who-have-taken-protease-inhibitors-133902https://curecurrent.com/trials/a-study-of-ritonavir-abt-538-when-used-with-nelfinavir-in-hiv-infected-patients-133903https://curecurrent.com/trials/a-study-of-ritonavir-indinavir-combination-in-hiv-infected-patients-133904https://curecurrent.com/trials/long-term-nutritional-support-in-patients-with-the-acquired-immunodeficiency-syndrome-comparison-of-liposyn-iii-2-percen-133905https://curecurrent.com/trials/the-safety-and-effectiveness-of-ritonavir-in-the-treatment-of-hiv-related-kaposi-s-sarcoma-133906https://curecurrent.com/trials/a-comparison-of-two-types-of-injected-nutritional-supplements-in-patients-with-aids-and-pneumocystis-carinii-pneumonia-p-133907https://curecurrent.com/trials/a-phase-iii-study-comparing-two-different-anti-hiv-drug-combinations-in-hiv-positive-patients-without-previous-anti-hiv-133908https://curecurrent.com/trials/phase-i-safety-study-of-anti-hiv-immune-serum-globulin-human-133909https://curecurrent.com/trials/efficacy-and-safety-of-pegifn-ftc-tdf-to-treat-chronic-hepatitis-b-in-hiv-coinfected-patients-133910https://curecurrent.com/trials/the-effect-of-bacille-calmette-guerin-bcg-vaccination-on-immune-responses-in-hiv-exposed-and-unexposed-infants-133911https://curecurrent.com/trials/peginterferon-and-ribavirin-on-virologic-and-immunologic-parameters-in-hepatitis-c-mono-and-coinfected-patient-privicop-133912https://curecurrent.com/trials/influence-of-drug-transporter-expression-on-the-pharmacokinetics-of-the-hiv-protease-inhibitor-kaletra-133913https://curecurrent.com/trials/venice-study-nevirapine-full-dose-dose-escalation-133914https://curecurrent.com/trials/the-intervention-with-microfinance-for-aids-and-gender-equity-image-study-133915https://curecurrent.com/trials/bioequivalence-study-of-didanosine-in-children-treated-for-hiv-133916https://curecurrent.com/trials/hiv-abuse-and-psychiatric-disorders-among-youth-133917https://curecurrent.com/trials/lopinavir-ritonavir-monotherapy-versus-standard-highly-active-antiretroviral-therapy-haart-in-hiv-hcv-coinfected-antiret-133918https://curecurrent.com/trials/an-affect-management-intervention-for-juvenile-offenders-133919https://curecurrent.com/trials/pharmacokinetic-study-of-two-hiv-protease-inhibitors-in-patients-133920https://curecurrent.com/trials/lopinavir-ritonavir-monotherapy-versus-standard-highly-active-antiretroviral-therapy-haart-in-hiv-hcv-coinfected-patient-133921https://curecurrent.com/trials/safety-study-of-elvucitabine-in-hiv-1-subjects-133922https://curecurrent.com/trials/cmv-disease-and-iris-in-hiv-1-infected-persons-133923https://curecurrent.com/trials/intestinal-protozoal-infections-and-sexual-transmitted-diseases-among-targeted-cohorts-133924https://curecurrent.com/trials/the-effect-of-probiotics-on-the-immune-status-diarrhea-and-bacterial-vaginosis-cure-rate-among-hiv-patients-133925https://curecurrent.com/trials/phase-iv-study-to-evaluate-the-efficacy-safety-to-extend-treatment-and-high-dose-of-ribavirin-in-co-infected-patients-133926https://curecurrent.com/trials/a-pilot-study-to-investigate-the-safety-and-immunologic-activity-ags-004-an-autologous-hiv-immunotherapeutic-agent-133927https://curecurrent.com/trials/pilot-study-with-isentress-raltegravir-and-epzicom-abacavir-lamivudine-in-treatment-naive-hiv-infected-subjects-133928https://curecurrent.com/trials/beta-2-microglobulin-and-serum-cytokines-x-haart-133929https://curecurrent.com/trials/immune-response-to-toll-like-receptor-9-agonist-adjuvanted-pneumococcal-vaccination-in-hiv-infected-adults-133930https://curecurrent.com/trials/incidence-and-severity-of-neuropsychiatric-adverse-events-of-efavirenz-given-as-a-stepped-dosage-vs-the-usual-dosage-133931https://curecurrent.com/trials/evaluation-of-enrollment-dynamics-of-care-and-patient-outcomes-in-the-nys-medicaid-hiv-special-needs-plans-133932https://curecurrent.com/trials/family-access-to-care-study-facs-133933https://curecurrent.com/trials/plasma-citrulline-concentration-in-tropical-enteropathy-133934https://curecurrent.com/trials/anti-herpetic-treatment-of-genital-ulcer-effect-on-hiv-herpes-shedding-anrs-1212-133935https://curecurrent.com/trials/randomised-trial-of-structured-treatment-interruption-of-haart-in-hiv-infected-adults-in-abidjan-anrs-1269-trivacan-133936https://curecurrent.com/trials/efficacy-and-safety-of-mk-0518-in-treatment-experienced-hiv-1-infected-adult-patients-with-hemophilia-133937https://curecurrent.com/trials/topical-cyclosporine-for-the-treatment-of-dry-eye-in-patients-infected-with-the-human-immunodeficiency-virus-133938https://curecurrent.com/trials/study-of-adherence-effects-and-clinical-outcomes-of-kaletra-based-hiv-antiviral-therapy-133939https://curecurrent.com/trials/influenza-vaccination-in-immunocompromized-patients-133940https://curecurrent.com/trials/study-to-evaluate-the-replacement-of-reverse-transcriptase-nucleoside-nucleotide-inhibitors-by-nevirapine-in-patients-on-133941https://curecurrent.com/trials/a-randomized-trial-of-three-regimens-to-prevent-tuberculosis-in-hiv-infected-patients-with-anergy-133942https://curecurrent.com/trials/lamivudine-plus-interferon-versus-lamivudine-for-the-treatment-of-hbeag-positive-chronic-hepatitis-b-virus-hbv-133943https://curecurrent.com/trials/pharmacokinetic-study-of-epzicom-tablet-133944https://curecurrent.com/trials/comparison-of-abacavir-following-once-daily-and-twice-daily-administration-in-hiv-infected-subjects-133945https://curecurrent.com/trials/a-study-of-patient-management-in-hiv-1-infected-patients-found-to-have-the-genetic-marker-hla-b-5701-133946https://curecurrent.com/trials/tucaresol-as-add-on-to-haart-highly-active-antiretroviral-therapy-in-chronic-hiv-1-infected-adults-133947https://curecurrent.com/trials/efficacy-of-influenza-vaccine-in-hiv-infected-adults-133948https://curecurrent.com/trials/raltegravir-and-atazanavir-replacing-current-suppressive-treatment-because-of-side-effects-in-current-treatment-133949https://curecurrent.com/trials/influenza-vaccination-at-a-reduced-dose-using-mesotherapy-in-hiv-aids-patients-at-the-hadassah-aids-center-jerusalem-133950https://curecurrent.com/trials/effect-of-an-online-video-based-intervention-to-increase-hiv-testing-in-men-who-have-sex-with-men-in-peru-133951https://curecurrent.com/trials/nursing-intervention-for-hiv-regime-adherence-among-people-with-serious-mental-illness-smi-133952https://curecurrent.com/trials/safety-and-efficacy-of-pro-542-in-the-treatment-of-hiv-infected-patients-133953https://curecurrent.com/trials/safety-of-and-immune-response-to-a-hepatitis-b-virus-vaccine-given-with-a-booster-cpg7909-odn-in-hiv-infected-and-hiv-un-133954https://curecurrent.com/trials/a-study-of-chlorhexidine-in-the-prevention-of-hiv-1-transmission-from-mothers-to-their-babies-133955https://curecurrent.com/trials/a-treatment-protocol-for-the-use-of-intravenous-ganciclovir-in-aids-patients-with-immediately-sight-threatening-cmv-reti-133956https://curecurrent.com/trials/a-treatment-protocol-for-the-use-of-trimetrexate-with-leucovorin-rescue-for-aids-patients-with-pneumocystis-carinii-pneu-133957https://curecurrent.com/trials/a-phase-iii-randomized-double-blind-controlled-study-of-the-use-of-anti-hiv-immune-serum-globulin-hivig-for-the-preventi-133958https://curecurrent.com/trials/a-phase-i-safety-and-immunogenicity-trial-of-the-facilitated-hiv-1-gag-pol-dna-vaccine-apl-400-047-apollon-inc-given-int-133959https://curecurrent.com/trials/computer-generated-vs-standard-informed-consent-for-hiv-research-studies-133960https://curecurrent.com/trials/safety-of-and-immune-response-to-polyvalent-hiv-1-vaccine-in-hiv-uninfected-adults-133961https://curecurrent.com/trials/an-electronic-pillbox-for-people-with-hiv-133962https://curecurrent.com/trials/safety-of-an-oral-hiv-vaccine-in-hiv-uninfected-volunteers-133963https://curecurrent.com/trials/bisphosphonate-therapy-for-hiv-infected-adults-with-decreased-bone-mineral-density-133964https://curecurrent.com/trials/immunologic-control-of-drug-resistant-hiv-133965https://curecurrent.com/trials/increasing-condom-use-in-people-at-risk-for-hiv-infection-133966https://curecurrent.com/trials/immune-function-of-infants-with-hiv-133967https://curecurrent.com/trials/d4t-or-abacavir-plus-vitamin-enhancement-in-hiv-infected-patients-dave-133968https://curecurrent.com/trials/3tc-or-no-3tc-for-hiv-with-3tc-resistance-133969https://curecurrent.com/trials/perceived-changes-in-body-build-and-image-in-patients-who-are-now-taking-or-recently-have-stopped-taking-anti-hiv-drugs-133970https://curecurrent.com/trials/a-comparison-of-two-tests-for-anti-hiv-drug-resistance-133971https://curecurrent.com/trials/studies-of-hiv-1-infection-in-newly-infected-individuals-in-southern-africa-133972https://curecurrent.com/trials/alcar-prophylaxis-study-133973https://curecurrent.com/trials/diagnosing-tuberculosis-in-hiv-infected-children-in-peru-133974https://curecurrent.com/trials/treatment-intensification-for-hiv-infected-patients-with-multi-drug-resistant-virus-133975https://curecurrent.com/trials/carotid-artery-thickness-in-hiv-infected-and-uninfected-adults-133976https://curecurrent.com/trials/alternative-dosing-strategy-for-anti-hiv-drugs-133977https://curecurrent.com/trials/a-study-of-patients-with-aids-syndrome-133978https://curecurrent.com/trials/a-study-to-monitor-the-health-of-participants-in-hivnet-014-who-become-infected-with-hiv-1-133979https://curecurrent.com/trials/effectiveness-of-anti-hiv-therapy-haart-in-hiv-infected-patients-with-tuberculosis-133980https://curecurrent.com/trials/a-phase-i-safety-and-immunogenicity-trial-of-ubi-multivalent-hiv-1-peptide-immunogen-in-hiv-1-seronegative-human-subject-133981https://curecurrent.com/trials/effectiveness-of-the-early-addition-of-abacavir-to-an-anti-hiv-drug-combination-133982https://curecurrent.com/trials/identifying-emergency-room-patients-who-have-recently-been-infected-with-hiv-133983https://curecurrent.com/trials/hiv-prevention-counseling-for-men-who-have-sex-with-men-133984https://curecurrent.com/trials/to-determine-if-there-are-pharmacokinetic-interactions-at-plasma-or-intracellular-level-between-nucleosides-and-tenofovi-133985https://curecurrent.com/trials/tmc-125-blood-levels-study-133986https://curecurrent.com/trials/occurrence-of-pneumocystis-pneumonia-in-hiv-infected-patients-and-the-interference-of-the-haart-133987https://curecurrent.com/trials/assessment-of-cytokine-values-in-serum-and-by-rt-pcr-in-hiv-1-individuals-with-and-without-haart-133988https://curecurrent.com/trials/l-carnitine-to-treat-fatigue-in-aids-patients-133989https://curecurrent.com/trials/the-effect-of-low-dose-human-growth-hormone-therapy-in-hiv-infected-patients-133990https://curecurrent.com/trials/a-study-of-d4t-in-patients-with-aids-or-aids-related-complex-who-cannot-take-azt-133991https://curecurrent.com/trials/a-study-of-azithromycin-plus-pyrimethamine-in-the-treatment-of-a-brain-infection-in-patients-with-aids-133992https://curecurrent.com/trials/a-phase-i-ii-trial-of-ribavirin-with-escalation-isoprinosine-in-asymptomatic-hiv-viremic-patients-133993https://curecurrent.com/trials/a-study-of-bmy-27857-in-patients-with-aids-or-aids-related-complex-133994https://curecurrent.com/trials/a-phase-i-safety-and-pharmacokinetics-study-of-2-3-dideoxyinosine-ddi-administered-twice-daily-to-infants-and-children-w-133995https://curecurrent.com/trials/a-phase-i-ii-study-to-evaluate-single-agent-and-combination-therapy-with-megestrol-acetate-and-dronabinol-for-the-treatm-133996https://curecurrent.com/trials/a-study-of-male-rectal-samples-in-preparation-for-future-rectal-microbicide-trials-133997https://curecurrent.com/trials/the-safety-and-effectiveness-of-didanosine-plus-stavudine-plus-delavirdine-mesylate-plus-mkc-442-in-hiv-infected-patient-133998https://curecurrent.com/trials/the-safety-and-effectiveness-of-didanosine-plus-stavudine-plus-nevirapine-combined-with-mkc-442-in-hiv-infected-patients-133999https://curecurrent.com/trials/computer-assisted-hiv-prevention-for-young-drug-users-134000https://curecurrent.com/trials/a-pilot-study-of-methodology-to-rapidly-evaluate-drugs-for-bactericidal-activity-tolerance-and-pharmacokinetics-in-the-t-134001https://curecurrent.com/trials/a-study-of-dideoxycytidine-plus-zidovudine-in-the-treatment-of-aids-or-advanced-aids-related-complex-arc-134002https://curecurrent.com/trials/immunogenicity-of-7-valent-pneumococcal-conjugate-vaccine-in-lung-fluid-of-adults-with-and-without-hiv-infection-134003https://curecurrent.com/trials/hiv-and-genital-herpes-among-high-risk-men-who-have-sex-with-men-msm-in-lima-peru-134004https://curecurrent.com/trials/safety-and-effectiveness-of-immunotherapy-with-autologous-hiv-specific-cd8-cells-in-hiv-infected-adults-134005https://curecurrent.com/trials/use-of-a-test-that-evaluates-how-the-body-handles-insulin-and-glucose-134006https://curecurrent.com/trials/hormonal-birth-control-and-the-risk-of-acquiring-hiv-134007https://curecurrent.com/trials/immediate-versus-deferred-antiretroviral-therapy-for-hiv-associated-tuberculous-meningitis-134008